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T hi s p a p er e x a mi n e s t h e r el ati o n s hi p b et w e e n I m p eri al  C h e mi c al I n d u stri e s
(I CI), t h e c o m p a ny t h at di s c o v er e d t a m o xif e n, a n d  Dr  Cr ai g J or d a n,  w h o
pl a y e d a  m aj or p art i n it s s u c c e s s a s a br e a st c a n c er dr u g, a n d  w h o  w or k e d
a s a c o n s ult a nt f or t h e c o m p a n y, b ut  wit h o ut e v er b ei n g p ai d a c o n s ult a n c y
f e e. I n st e a d, I CI f u n d e d j u ni or st aff  w or ki n g i n hi s l a b or at or y o n t o pi c s of
hi s c h oi c e. T h e y l at er p ai d hi s e x p e n s e s a s a n e x p ert  wit n e s s i n p at e nt-liti g ati o n
c a s e s, a s a r e s ult of  w hi c h t h e  U S b e c a m e a  m aj or l u cr ati v e  m ar k et f or t a m o x-
if e n, a n d I CI’s ot h er a nti- c a n c er dr u g s. T hi s c a s e st u d y ill u str at e s t h at, li k e c o n-
s ult a nt s, dr u g s pl a y a n i m p ort a nt p art at t h e b o u n d ar y b et w e e n t h e a c a d e mi c
a n d i n d u stri al s p h er e s.  H o w e v er, e v e n if it i s bl urr e d, t h e b o u n d ar y r e m ai n s.
O wi n g t o t h e s e cr e c y t h at oft e n s urr o u n d s i n d u stri al r e s e ar c h, t hi s b o u n d ar y
m a y l e a d t o a diff er e nt u n d er st a n di n g of  w h at c o n stit ut e s i n n o v ati o n, a n d t o
diff er e nt n arr ati v e s  wit h r e g ar d t o r e s p e cti v e c o ntri b uti o n s.
I ntr o d u cti o n
E v er si n c e t h e y st art e d t o est a blis h a s ci e n c e b as e at t h e b e gi n ni n g of t h e t w e nti et h
c e nt ur y b y i n c or p or ati n g r es e ar c h l a b or at ori es  wit hi n f a ct ori es or b uil di n g c e ntr es
d e di c at e d t o r es e ar c h, p h ar m a c e uti c al c o m p a ni es h a v e r eli e d u p o n a c a d e mi c s ci e n-
tists as c o ns ult a nts t o e ns ur e t h at t h e y  w o ul d a c c ess c utti n g- e d g e r es e ar c h a n d g ai n
a c o m p etiti v e a d v a nt a g e i n n o v el t h er a p e uti c fi el ds. 1 As p u bli cl y f u n d e d r es e ar c h
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i nstit uti o ns d e v el o p e d o v er t h e c o urs e of t h e t w e nti et h c e nt ur y, fir ms als o t ur n e d t o
t h e s ci e ntist- m a n a g ers r u n ni n g t h es e i nstit uti o ns or a d visi n g g o v er n m e nts f or  m or e
g e n er al a n d str at e gi c dir e cti o n. 2 M or e r e c e ntl y, dr u g c o m p a ni es h a v e e nlist e d t h e
h el p of  m a n a g e m e nt c o ns ult a nts,  m a n y of t h e m  wit h b a c k gr o u n ds i n t h e n at ur al or
p h ysi c al s ci e n c es, f or g ui d a n c e i n r es e ar c h or g a nis ati o n a n d g o v er n a n c e. 3 H o w e v er,
p h ar m a c e uti c al fir ms als o t ar g et e d t h e g at e- k e e p ers of  m e di c al o pi ni o n t o k e e p
a br e ast of n e w tr e n ds, t est t h eir pr o d u cts, a n d ( m or e oft e n t h a n n ot) i nfl u e n c e
m e di c al pr a cti c e. 4 Wit h t h e birt h of  w elf ar e st at es, a n d as dr u g s af et y l e gisl ati o n
b e c a m e  m or e d e m a n di n g i n or d er t o pr ot e ct t h e  wi d er p u bli c fr o m p ot e nti al dr u g dis as-
t ers, t h e r el ati o ns hi p b et w e e n p h ar m a c e uti c al fir ms a n d  m e di c al pr a ctiti o n ers  w or ki n g
i n h os pit al s etti n gs a n d p erf or mi n g cli ni c al tri als a c q uir e d e v e n gr e at er pr o mi n e n c e.5
P artl y as a r es ult of t his e v ol uti o n, t h e lit er at ur e o n t h e p h ar m a c e uti c al i n d ustr y
h as t e n d e d t o b e c o m e s plit b et w e e n t w o str a n ds; t h e first e m p h asisi n g t h e r ol e of
a c a d e mi c-i n d ustri al r el ati o ns i n f ost eri n g bi o m e di c al i n n o v ati o n, a n d t h e s e c o n d
hi g hli g hti n g t h e  m or al dil e m m as a n d et hi c al c o m pr o mis es  w hi c h s u c h cl os e c o n n e c-
ti o ns e nt ail.6 It is t h er ef or e b ot h ti m el y a n d us ef ul t o e x a mi n e t h e r el ati o ns hi p fr o m
b ot h p ers p e cti v es – t h e c o m p a n y a n d t h e c o ns ult a nt – a n d c o n si d er t h e t e nsi o ns as
w ell as t h e r e w ar d s  w hi c h it  m a y bri n g.  T his is  w h at t h e pr es e nt p a p er i nt e n ds t o d o,
b y f o c usi n g o n a s p e cifi c c as e st u d y: t h e r el ati o ns hi p b et w e e n I m p eri al  C h e mi c al I n-
d ustri es (I CI),  w hi c h d e v el o p e d t a m o xif e n, a n d  Cr ai g J or d a n,  w h o n ot o nl y h el p e d
t o t ur n t a m o xif e n i nt o a lif e-s a vi n g a n d b est-s elli n g br e ast c a n c er dr u g, b ut  w e nt o n
t o l a y t h e f o u n d ati o ns f or, a n d d e v el o p, ot h er s u c c e ssf ul S E R M s ( S el e cti v e  Estr o g e n
R e c e pt or  M o d ul at o rs).  Usi n g a c o m bi n ati o n of s o ur c es – p u blis h e d b o o ks a n d arti-
cl es, u n p u blis h e d c o m p a n y r es e ar c h r e p orts, a n d a hist or y of t a m o xif e n  writt e n b y
D or a  Ri c h ar ds o n, t h e c o m p a n y c h e mist  w h o s y nt h esis e d it, as  w ell as p ers o n al c o m-
m u ni c ati o ns a n d or al i nt er vi e ws – t h e p a p er  will e x pl or e t h e c o ntri b uti o n s a n d  m o-
ti v ati o ns fr o m b ot h si d es. It  will ill ustr at e h o w, i n t h e p eri o d u n d er st u d y,
p h ar m a c e uti c al i n n o v ati o n  w as as  m u c h t h e pr o d u ct of t h e i niti ati v es of i n di vi d u al
r es e ar c h ers, b ot h i nsi d e a n d o utsi d e t h e c o m p a n y, as t h e r es ult of t h e c o m p a n y
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m a n a g ers ’ visi o ns a n d d e cisi o ns i m p os e d fr o m a b o v e.  M or e o v er, it  will s h o w t h at,
li k e c o ns ult a nts, dr u g s cir c ul at e b et w e e n t h e a c a d e mi c a n d i n d ustri al s p h er es, bl ur-
ri n g t h e b o u n d ar y b et w e e n t h e m. 7
Cr ai g J or d a n a n d I CI
J or d a n ’s i niti al i nt er est as a s c h o ol b o y  w as c h e mistr y:
At g r a m m a r s c h o ol,  m y  m ai n p a s si o n  w a s f o r c h e mi st r y a n d, i n a  m o m e nt of i n s a nit y,
m y  m ot h e r all o w e d  m e t o s et u p a l a b i n  m y b e d r o o m. I p oi s o n e d  m y s elf  wit h c hl o-
ri n e g a s, s et fi r e t o t h e c u rt ai n s a n d kill e d t h e g r a s s o ut si d e  m y  wi n d o w. It g r e w b a c k
bl u e!
I al w a ys  w a nt e d t o b e a c h e mistr y t e c h ni ci a n at I CI P h ar m a c e uti c als,  w hi c h l at er b e c a m e
Astr a Z e n e c a, n e ar  w h er e I li v e d i n  C h es hir e.  B ut t h e c ar e ers  m ast er s ai d t h at I s h o ul d g o
t o u ni v ersit y b e c a us e I  w as a n u n us u al b o y a n d, b y t h at ti m e, I’d s et u p a l a b at s c h o ol
a n d  w as t e a c hi n g c h e mistr y t o ot h er p u pils i n t h e l u n c h h o ur. 8
H e n c e, J or d a n ’s first c o nt a ct  wit h I CI di d n ot o c c ur u ntil l at er, i n 1 9 6 7, as a s u m m er
st u d e nt i n t h e first y e ar of his  B S c i n t h e  D e p art m e nt of P h ar m a c ol o g y at  L e e ds.  H e
c a m e t o I CI ’s p h ar m a c e uti c al r es e ar c h c e ntr e,  Al d erl e y P ar k, t o  w or k  wit h St e p h e n
C art er,  w h o  w as st u d yi n g c yt o c h al asi ns at t h e ti m e as p art of a pr o gr a m m e of r e-
s e ar c h o n  C ell  Di visi o n a n d  Gr o wt h. 9 C art er h a d j ust p u blis h e d a n arti cl e a b o ut
it i n N at ur e ,  w hi c h J or d a n c a m e a cr oss d uri n g his st u di es.1 0 H e r e c all e d first
m e eti n g  wit h  C art er:
I  w e nt h o m e t o  C h es hir e, t o o k a b us t o  Al d erl e y P ar k a n d p h o n e d hi m u p fr o m t h e c all
b o x o utsi d e t h e g at es.  T h e o p er at or o n t h e I CI s wit c h b o ar d c o n n e ct e d  m e a n d aft er c h at-
ti n g f or a  w hil e h e s ai d “ N e xt ti m e y o u ar e b a c k i n  Al d erl e y  E d g e arr a n g e a n i nt er vi e w. ”
“ A ct u all y, I a m h er e n o w o utsi d e t h e fr o nt g at e! ” a n d I  w as i n a n d I h a d t h e s u m m er j o b.
H e h a d a t o u g h ti m e  wit h  m e. I  w as n ot h a p p y  wit h sitti n g sil e ntl y f or 3 0  mi n at t h e t e a
a n d c off e e l a b br e a ks. I  w e nt e a c h d a y t o t h eir  w o n d erf ul li br ar y a n d f o u n d a c h e mi c al
w e s h o ul d c o nsi d er f or t esti n g as a n a nti c a n c er a g e nt.  All a bit  m u c h f or his gr o u p!!  N e v-
ert h el ess,  W all o p ’s ( W al p ol e) gr o u p  w as o p p osit e a n d  w e  w e nt o ut t o a  C hi n es e r est a u-
r a nt e a c h Fri d a y.  N e xt d o or  w as  Mi k e  B arr ett i n c h ar g e of b et a- bl o c k er r es e ar c h,  wit h a
t e c h ni ci a n  w h o  w as a n e x- girlfri e n d of  mi n e.  D or a ( Ri c h ar ds o n), i n a n ot h er b uil di n g h a d
a t e c h ni ci a n  w h o m I h a d a cr us h o n at pri m ar y s c h o ol.  A L L I N  A L L a n i nt er esti n g
s u m m er.
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d ar y  O bj e cts:  A m at e urs a n d Pr of essi o n al s i n  B er k el e y ’s  M us e u m of  Vert e br at e  Z o ol o g y, 1 9 0 7 – 1 9 3 0, ” S o ci al St u di es
of S ci e n c e 1 9 ( 1 9 8 9): 3 8 7 – 4 2 0.
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9 C yt o c h al asi ns ar e f u n g al  m et a b olit es  wit h t h e a bilit y t o c h a n g e t h e  m or p h ol o g y of c ells, i n hi bit c ell di visi o n, a n d e v e n
c a u s e a p o pt osis ( or pr o gr a m m e d c ell d e at h).  T his  w as o n e a p pr o a c h t o t h e pr o bl e m of c a n c er b ei n g c o nsi d er e d at t h e
ti m e  wit hi n I CI.
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A n y w a y t h at s u m m er I  m et e v er y o n e  w h o  w o ul d c h a n g e  m y lif e, a n d ulti m at el y t h e
w orl d of  w o m e n ’s h e alt h [ … ]  Mi k e  B arr ett b e c a m e  m y h e a d of d e p art m e nt at  L e e ds,
g ot  m e a l e ct ur es hi p.  W all o p t o e x a mi n e  m y P h D t h esis a n d  D or a t o gi v e  m e t a m o xif e n
m et a b olit es, t h at l e d ulti m at el y t o r al o xif e n e a n d  m e t o dis c o v er S E R Ms. 1 1
T h e f a ct t h at  Al d erl e y P ar k  w as sit u at e d n e ar J or d a n ’s h o m e i n  C h es hir e, a n d t h at b y
t h e ti m e h e  w e nt t h er e i n 1 9 6 7 I CI’s t a m o xif e n pr oj e ct  w as u n d er  w a y,  w as s er e n di p-
it o us.  H o w e v er, J or d a n’s first e x p eri e n c e of  w or ki n g at  Al d erl e y P ar k  w o ul d n ot
o nl y – t h a n ks t o t a m o xif e n – “ c h a n g e [ his] lif e, a n d ulti m at el y t h e  w orl d of
w o m e n ’s h e alt h, ” b ut als o i n t h e l o n g t er m b e n efit I CI ’s P h ar m a c e uti c al  Di visi o n,
a n d t h e c o m p a n y  m or e  wi d el y.  T h e r el ati o ns hi p t h at d e v el o p e d b et w e e n J or d a n
a n d I CI  w as t h er ef or e  m ut u all y b e n efi ci al, a n d t o u n d erst a n d h o w a n d  w h y it
e v ol v e d i nt o a f or m al arr a n g e m e nt c e ntr e d o n a p arti c ul ar pr o d u ct, o n e  m ust g o
b a c k t o t h e ori gi ns of t a m o xif e n,  w hi c h l a y i n t h e c o m p a n y ’s d u al i nt er est i n
c a n c er a n d c o ntr a c e pti o n.
I CI a n d c a n c er r e s e ar c h
T h e c o m p a n y ’s i nt er est i n c a n c er  w as r el at e d t o its  w arti m e a cti viti es, a n d l o n g pr e-
d at e d t a m o xif e n. 1 2 Art h ur  W al p ol e, a bi ol o gist  w h o i n 1 9 3 8 h a d j oi n e d t h e  M e di c-
i n al S e cti o n of I CI’s  D y est uff s  Di visi o n i n  Bl a c kl e y, a n d d uri n g t h e  w ar  w or k e d o n
a n al g esi cs, s p as m ol yti c s, a n d h or m o n es,  w hi c h  w er e k n o w n t o pl a y a p art i n
c ert ai n t y p es of c a n c er, b e g a n r es e ar c hi n g t h e t o pi c. S o b e g a n I CI ’s l e n gt h y a n d
c o m pl e x s e ar c h f or a n eff e cti v e a nti- c a n c er a g e nt,  w hi c h  wit hi n t h e c o m p a n y
w o ul d bri n g t o g et h er c h e mists a n d bi ol o gists  w or ki n g o n diff er e nt pr oj e cts, st atisti-
ci a ns t o a n al ys e t h eir r es ults, a n d o utsi d e t h e c o m p a n y  w o ul d  m o bilis e h os pit al cli-
ni ci a ns t o c arr y o ut tri als, a n d a c a d e mi cs t o c arr y o ut r es e ar c h, i n a  m assi v e
c oll a b or ati v e eff ort t h at  w o ul d e v e nt u all y l e a d t o t a m o xif e n.
At first, I CI ’s a p pr o a c h t o c a n c er  w as l ar g el y e m piri c al, i n v ol vi n g t h e s y nt h esis of d e-
ri v ati v es of c o m p o u n ds  wit h k n o w n a nti-t u m o ur pr o p erti es.  O n e of t h es e  w as tri p h e-
n yl et h yl e n e ( T P E), a d eri v ati v e of t h e p ot e nt a nti- o estr o g e ni c di et h ylstil b o estr ol ( D E S),
w hi c h h a d a d ur a bl e, al b eit  w e a k a nti- o estr o g e ni c a cti o n.  W al p ol e ’s e x pl or at or y  w or k
wit h t h e s u bst a n c e l e d t o t h e s y nt h esis of v ari o us  T P E d eri v ati v es, i n cl u di n g tri p h e n yl-
c hl or o et h yl e n e (r e gist er e d i n 1 9 4 0 u n d er t h e n a m e  G y n os o n e). 1 3 I n 1 9 4 2, t h es e c o m-
p o u n ds  w er e s u p pli e d f or tri als i n br e ast c a n c er t o (l at er Sir)  Al e x a n d er  H a d d o w of
t h e  C h est er  B e att y I nstit ut e (s u bs e q u e ntl y t h e I nstit ut e of  C a n c er  R es e ar c h) i n
L o n d o n, a n d t o  E dit h P at ers o n at t h e  C hristi e  H os pit al i n  M a n c h est er.  Alt h o u g h
1 1 V.  C. J or d a n, p ers o n al e m ail c o m m u ni c ati o n t o t h e a ut h or ( h er e aft er p ers. c o m m.) ( 2 2/ 0 9/ 1 7).
1 2 F or hist ori es of I CI, s e e  W. J.  R e a d er, I m p eri al  C h e mi c al I n d ustri e s ( O xf o r d:  O xf o r d  U ni v ersit y Pr ess, 1 9 7 0), v ol. 1;
C.  K e n n e d y, I CI:  T h e  C o m p a n y t h at  C h a n g e d o ur  Li v es ( L o n d o n:  H ut c hi ns o n, 1 9 8 6).  M or e s p e cifi c all y o n I CI’s
a nti- c a n c er pr oj e ct, s e e  Q uir k e, “ St a n d ar di zi n g  R & D; ” s e e als o  V.  Q uir k e, “ T a m o xif e n fr o m F ail e d  C o ntr a c e pti v e
Pill t o  B est- s elli n g  Br e a st  C a n c er  M e di ci n e:  A  C as e-st u d y i n P h ar m a c e uti c al I n n o v ati o n, ” Fr o nti ers i n  P h ar m a c ol o g y
( 1 2 S e pt. 2 0 1 7): 1 6 6 3– 9 8 1 2.
1 3 D.  N.  Ri c h ar d s o n, “ T h e  Hist o r y of  N ol v a d e x ” ( Astr a Z e n e c a - h er e aft er  A Z - P H 2 7 0 3 9  B, 1 3  M a y 1 9 8 0).  T his a p-
p e ar e d l at er i n a n a bri d g e d f or m as  D.  N.  Ri c h ar d s o n, “ T h e  Hist or y of  N ol v a d e x, ” Dr u g  D esi g n a n d  D eli v er y
( 1 9 8 8): 1– 1 4.
2 9 2 VI VI A N E  Q UI R K E
i m pr o v e m e nts  w er e o nl y t e m p or ar y, t h er e  w as cl e ar e vi d e n c e t h at  G y n os o n e i n p arti c-
ul ar c a us e d t u m o ur r e gr essi o n a n d t h er ef or e c o ul d b e b e n efi ci al i n t h e tr e at m e nt of
br e ast c a n c er.
M e a n w hil e, o n t h e ot h er si d e of t h e  Atl a nti c, t h e c o m p o u n ds k n o w n as “ nitr o g e n
m ust ar ds, ” w hi c h  w er e b ei n g st u di e d as p art of a c h e mi c al  w arf ar e r es e ar c h pr o-
gr a m m e,  w er e s h o w n t o i n hi bit t h e gr o wt h of bl o o d a n d l y m p h t u m o urs b y
G o o d m a n a n d  Gil m a n at  Y al e  U ni v ersit y, a dis c o v er y oft e n h ail e d as t h e b e gi n ni n g
of c a n c er c h e m ot h er a p y. 1 4 D es pit e t his  w arti m e  w or k b ei n g t o p-s e cr et,  W al p ol e a n d
H a d d o w  w er e als o a bl e t o i n v esti g at e t h es e c o m p o u n ds, t h a n ks t o a n  A n gl o- A m eri c a n
a gr e e m e nt t o e x c h a n g e s ci e ntifi c i nf or m ati o n.  A n ot h er, p ar all el, st u d y r el ati n g t o
c a n c er at I CI i n v ol v e d a nti- m et a b olit es u n d er t h e l e a d ers hi p of F.  L. ( “ Fr a n k ” ) R os e.
R os e, a n a z o d y e c h e mist  w h o h a d j oi n e d t h e  D y est uffs  Di visi o n i n 1 9 3 2, b e c a m e  R e-
s e ar c h  M a n a g er of its  C h e mistr y  D e p art m e nt i n 1 9 5 4,  w hilst r e m ai ni n g i n v ol v e d i n
b e n c h  w or k.  As  w ell as t h e s e ar c h f or al k yl ati n g a g e nts, s y nt h eti c o estr o g e ns a n d a nti-
m et a b olit es, h e e n c o ur a g e d i n v esti g ati o ns i nt o c ar ci n o g e n esis.  T his  w as a n u n us u al i n-
t er est f or r es e ar c h ers  w or ki n g o n c a n c er c h e m ot h er a p y at t h at ti m e,1 5 a n d  w as li n k e d t o
I CI’s c o n c er ns o v er e x p os ur e t o c ar ci n o g e ns i n c h e mi c al  m a n uf a ct ur e. 1 6
I CI di d n ot h a v e a f or m al c a n c er r es e ar c h pr o gr a m m e u ntil pl a ns  w er e  m a d e t o
b uil d a p h ar m a c e uti c al r es e ar c h c e ntr e at  Al d erl e y P ar k (s o ut h of  M a n c h est er),
w hi c h c oi n ci d e d  wit h I CI st arti n g t o or g a nis e its r es e ar c h i n t e a m pr oj e cts.  C a n c er
b e c a m e s u c h a pr oj e ct i n 1 9 5 5. It  w as e ntitl e d “ C a n c er a n d  Vir us es:  A nti b a ct eri als. ”
Al d erl e y P ar k o p e n e d i n 1 9 5 7, a n d “ Vir us es ” b e c a m e a s e p ar at e pr oj e ct,  w hil e
“ C a n c er ” m er g e d  wit h a n e w pr oj e ct t o fi n d a n or al c o ntr a c e pti v e, l e d b y  Art h ur
W al p ol e.  T h e n, i n 1 9 6 0, t h e dis c o v er y of t h e n at ur al a nti vir al s u bst a n c e i nt erf er o n,
w hi c h  w as als o b ei n g i n v esti g at e d as a tr e at m e nt f or c a n c er, a n d I CI ’s i n v ol v e m e nt
i n its st u d y i n c oll a b or ati o n  wit h t h e  M e di c al  R es e ar c h  C o u n cil ( M R C), l e d t o
“ Vir us es ” a n d “ C a n c er ” c o mi n g t o g et h er a g ai n. “ Or al  C o ntr a c e pti o n ” w as t h er ef or e
s plit a w a y fr o m “ C a n c er, ” wit h  W al p ol e  w or ki n g i n p ar all el o n b ot h pr oj e cts.  His i n-
v ol v e m e nt  w o ul d e ns ur e t h at br e ast c a n c er r e m ai n e d a n i m p ort a nt f o c us f or b ot h his
t e a ms. It  w as  wit hi n t his “ Or al  C o ntr a c e pti o n ” pr oj e ct t h at t a m o xif e n, a  T P E d eri v-
ati v e,  w as s y nt h esis e d a n d s u bs e q u e ntl y d e v el o p e d, i niti all y as a c o ntr a c e pti v e pill.
I CI, or al c o ntr a c e pti o n a n d t h e ori gi n s of t a m o xif e n
T h e first c o ntr a c e pti v e pill h a d b e e n d e v el o p e d i n t h e e arl y 1 9 5 0s, a n d i n 1 9 5 6
W al p ol e  wr ot e a s ur v e y e ntitl e d “ T h e  Te c h ni c al P ossi bilit y of  Or al  C o ntr a c e pti o n, ”
w hi c h – as h a d b e c o m e c ust o m ar y  wit hi n I CI b y t h at ti m e – g a v e a n o v er vi e w of t h e
1 4 T h es e c o m p o u n d s  w er e l at er u n d erst o o d t o  w or k b y al k yl ati o n – i. e., t h e tr a nsf er of a n al k yl gr o u p fr o m o n e  m ol-
e c ul e t o a n ot h er, i n t h e c as e of a nti- c a n c er a g e nts att a c hi n g it t o  D N A, t h us i n hi biti n g c a n c er c ell di visi o n – h e n c e s u c h
c o m p o u n ds b e c a m e k n o w n as “ al k yl ati n g a g e nts. ”
1 5 C.  W. S u c kli n g a n d  B.  W.  L a n gl e y, “ Fr a n cis  L esli e  R os e, ” Bi o gr a p hi c al  M e m oi rs of F ell o ws of t h e  R o y al S o ci et y 3 6
( 1 9 9 0): 4 9 1– 5 2 4 ( o n 5 0 7 – 8).
1 6 G e or g e  B.  Hill, Al d erl e y  P ar k  Dis c o v er e d:  Hist o r y,  Wil dlif e,  P h ar m a c e uti c als ( L a n c ast er: P al ati n e  B o o ks, 2 0 1 6),
1 8 8.
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fi el d t o e n a bl e I CI t o d e ci d e  w h et h er it  w as  w ort h e nt eri n g.1 7 T a ki n g i nt o a c c o u nt
b ot h t h e r e q uir e m e nts f or c o ntr a c e pti o n a n d t h e n e e d t o a v oi d t o xi c eff e cts, t h e
s e ar c h f or  T P Es, al o n g si d e i n v esti g ati o ns of n at u r al a n d p art-s y nt h esis e d st er oi ds,
b e c a m e t h e pr ef err e d c o urs e of a cti o n.
T h e  m ost pr o misi n g c o m p o u n d t o c o m e o ut of t his pr o gr a m m e, I CI 3 3, 8 2 8
( w hi c h li k e all ot h e r c o m p o u n ds h a d b e e n gi v e n a n u m b er i n di c ati n g its pl a c e
al o n g t h e s e q u e n c e of I CI s y nt h es es),  w as t est e d i n pr e- m e n o p a us al p ati e nts  wit h
m a m m ar y c ar ci n o m a, o n t h e gr o u n ds t h at it  mi g ht h a v e a t h er a p e uti c as  w ell as
a n a nti-f ertilit y eff e ct. S h ortl y aft er w ar ds, i n 1 9 6 2,  Mi k e  H ar p er, a n e n d o cri n ol o gist,
w as i n vit e d t o j oi n t h e t e a m.  His n e w s eri es of bi ol o gi c al t ests pr o d u c e d a cl e ar er
pi ct ur e of t h e str u ct ur e- a cti vit y r el ati o ns hi ps of  T P Es, a n d t h e pr o gr a m m e of c h e m-
i c al s y nt h esis  w as st e p p e d u p.  T h e n e wl y s y nt h esis e d c o m p o u n ds i n cl u d e d I CI
4 6, 4 7 4 (l at er k n o w n as t a m o xif e n, br a n d n a m e  N ol v a d e x),  w hi c h  w as  m a d e i n
1 9 6 2 b y  D or a  Ri c h ar ds o n, a c h e mist  w h o h a d j oi n e d t h e  D y est uffs  Di visi o n i n
1 9 4 3.  B y a pr o c ess of fr a cti o n al cr yst allis ati o n d es cri b e d as “ r e v ol uti o n ar y at t h e
ti m e,” 1 8 s h e s u c c e e d e d i n s e p ar ati n g its cis a n d tr a ns is o m ers,  w hi c h r e v e al e d t h at
t h e a cti vit y r esi d e d i n t h e  m ol e c ul e’s  m ai n tr a ns is o m er (I CI 4 6, 4 7 4) r at h er t h a n
its  mi n or cis is o m er (I CI 4 7, 6 9 9).1 9 H ar p er t h er ef or e s el e ct e d I CI 4 6, 4 7 4 f or a d di-
ti o n al t ests a n d f or pr eli mi n ar y t o xi cit y st u di es.
S o o n aft er, t h e c o m p a n y l o d g e d p at e nt a p pli c ati o ns f or I CI 4 6, 4 7 4 a n d r el at e d
c o m p o u n ds.  As  w ell as pr o vi di n g b asi c d at a o n t h es e c o m p o u n ds, P at e nt
G B 1 0 1 3 9 0 7 c o v e r e d a n u m b er of p ot e nti al t h er a p e uti c us es, i n cl u di n g c a n c er. It
r e a d:
T h e al k e n e d eri v ati v es of t h e i n v e nti o n ar e us ef ul f or t h e  m o difi c ati o n of t h e e n d o cri n e
st at us i n  m a n a n d a ni m als a n d t h e y  m a y b e us ef ul f or t h e c o ntr ol of h or m o n e- d e p e n d e nt
t u m o urs or f or t h e  m a n a g e m e nt of t h e s e x u al c y cl e a n d a b err ati o ns t h er ef or e.  T h e y  will
als o h a v e us ef ul h y p o c h ol est er a e mi c a cti vit y. 2 0
I CI 4 6, 4 7 4 ( 1 9 6 2– 1 9 7 1)
T h e e arl y p h as e of t h e “ Or al  C o ntr a c e pti o n ” pr o gr a m m e s h a p e d t a m o xif e n a n d its
f ut ur e.  T h e c o m p o u n ds d e v el o p e d  wit hi n t his pr o gr a m m e  w er e d esi g n e d t o a ct as
c o ntr a c e pti v e pills, y et fr o m t h e b e gi n ni n g t h eir us ef ul n ess i n br e ast c a n c er  w as
als o e x pl or e d.  W al p ol e ’s o w n r es e ar c h i nt er ests r es ult e d i n t his d u al o bj e cti v e,
w hi c h  w as s ust ai n e d t h a n ks t o t h e fr uitf ul c oll a b or ati o ns h e est a blis h e d o utsi d e
t h e c o m p a n y b ot h  wit h e n d o cri n ol o gists a n d  wit h cli ni ci a ns  w or ki n g i n c a n c er.
1 7 S e e  V.  Q uir k e, “ Fr o m  E vi d e n c e t o  M ar k et:  Alfr e d S pi n ks ’s 1 9 5 3 S ur v e y of  N e w Fi el ds f or P h ar m a c ol o gi c al  R es e ar c h,
a n d t h e  Ori gi ns of I CI ’s  C ar di o v as c ul ar Pr o gr a m m e, ” i n M e di ci n e, t h e  M ar k et a n d t h e  M ass  M e di a:  Pr o d u ci n g
H e alt h i n t h e  C 2 0t h , e d.  V.  B erri d g e a n d  K.  L o u g hli n ( N e w  Y or k/ L o n d o n:  R o utl e d g e, 2 0 0 5), 1 4 6– 7 1.
1 8 J o h n P att ers o n, p ers. c o m m. ( 2 0/ 0 4/ 0 9).
1 9 G.  R.  B e df o r d a n d  D.  N.  Ri c h ar ds o n, “ Pr e p ar ati o n a n d I d e ntifi c ati o n of Cis a n d Tr a ns Is o m ers of a S u bstit ut e d  Tri-
p h e n yl et h yl e n e, ” N at ur e 2 1 2 ( 1 9 6 6): 7 3 3.
2 0 Q u ot e d i n P.  Y.  M a xi m o v,  R.  E.  M c D a ni el, a n d  V.  C. J or d a n, T a m o xif e n:  Pi o n e eri n g  M e di ci n e i n  Br e ast  C a n c er
( L o n d o n: S pri n g er, 2 0 1 6), 3 9.
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I m p ort a ntl y, it  m e a nt a c o nst a nt pr e o c c u p ati o n  wit h si d e eff e cts, a n d t h e l o w t o xi c-
it y of t a m o xif e n r el ati v e t o its p ot e n c y  w o ul d t ur n o ut t o b e o n e of its cr u ci al a d v a n-
t a g es o v er its c o m p etit ors.2 1
I CI 4 6, 4 7 4 h a d b e e n d e m o nstr at e d as t h e  m ost p ot e nt a n d l e ast t o xi c of all t h e
c o m p o u n ds t est e d b y J u n e 1 9 6 4.  H o w e v er, i n t esti n g t h e c o m p o u n d i n pr e p ar ati o n
f or a s u b missi o n t o t h e  C o m mitt e e of S af et y of  Dr u gs ( C S D), t h e n e w r e g ul at or y
b o d y t h at h a d b e e n s et u p i n t h e  w a k e of t h ali d o mi d e, u n c ert ai nt y ar os e as t o its
m o d e of a cti o n.  B e c a us e s u c h d o u bts c o ul d b est b e s ettl e d i n t h e cli ni c, pl a ns  w er e
m a d e i n 1 9 6 5 f or t h e first tri als.  A p pr o v al t o c arr y o ut t h er a p e uti c st u di es of t a m o x-
if e n f or t h e tr e at m e nt of a n o v ul ati o n or  m e n orr h a gi a ( at  A b er d e e n,  M a n c h est er, a n d
t h e  W o m e n’s  H os pit al i n  C h els e a), a n d of br e ast c ar ci n o m a i n t hirt y  m e n o p a us al
a n d p ost- m e n o p a us al  w o m e n ( at t h e  C hristi e  H os pit al i n  M a n c h est er)  w as o bt ai n e d
i n 1 9 6 9 fr o m t h e  C S D’s s u c c ess or, t h e  C o m mitt e e f or t h e S af et y of  M e di ci n es ( C S M).
T h e pr eli mi n ar y r e p orts r e c ei v e d fr o m  A b er d e e n a n d  L o n d o n h el p e d t o c ast f urt h er
li g ht o n t h e dr u g’s  m e c h a nis m of a cti o n, s h o wi n g t h at t a m o xif e n  w as c a p a bl e of i n-
d u ci n g o v ul ati o n at hi g h er d os e l e v els,  w hil e at l o w er d os es it t e n d e d t o h a v e a n a nti-
o estr o g e ni c eff e ct.  As t o t h e  C hristi e br e ast c a n c er tri al, alt h o u g h t w o of t h e  w o m e n
c o m pl ai n e d a b o ut h ot fl us h es ( w hi c h  w as t a k e n as e vi d e n c e of its a nti- o estr o g e n
eff e ct), n o t o xi cit y  w as o bs e r v e d a n d t h e dr u g a p p e ar e d t o b e  w ell t ol er at e d.
I n h er u n p u blis h e d hist or y of t a m o xif e n,  Ri c h ar d s o n  wr ot e of t h e t e a m’s e x cit e-
m e nt as t h e first tri al r es ults arri v e d. S h e d es cri b e d t h e n e ws of t h e birt h of a c hil d
t o a  w o m a n  w h o h a d b e e n i nf ertil e f or t w el v e y e ars as a “ b o ost t o  m or al e. ” 2 2 T h e
t e a m  w er e als o e n c o ur a g e d b y t h e br e ast c a n c er tri al, e v e n t h o u g h its r es ults  w er e
n ot r e c ei v e d  wit h u ni v ers al e nt h usi as m at I CI:  W al p ol e a n d his c oll e a g u es  w er e t ol d
t h at t h e y  w er e s u p p os e d t o b e l o o ki n g f or a c o ntr a c e pti v e pill, n ot a n a nti- c a n c er
a g e nt!  At a  D e v el o p m e nt  D e p art m e nt  m e eti n g o n 2 8  A u g ust 1 9 7 0, s al es esti m at es
a n d q u a ntiti es of b ul k dr u g  w er e s et at o nl y t w o k g f or i niti al st o c ks.  Ri c h ar d s o n c o n-
cl u d e d fr o m t h es e fi g ur es t h at t h e  D e p art m e nt o b vi o usl y e n vis a g e d tr e ati n g o nl y
“ d e a d p e o pl e. ” 2 3 Alt h o u g h h er c o n cl usi o n r efl e ct e d t h e h o p el ess n ess of t h e c o n diti o n
as it  w as vi e w e d at t h at ti m e, o n t h e b asis of t h e p ositi v e cli ni c al r es ults, t h e  C S M
gr a nt e d t h e c o m p a n y p er missi o n t o pr ol o n g t h e tri als a n d e xt e n d t h e m t o ot h er
c e ntr es.  B y t h e e n d of 1 9 7 0, si xt y p ati e nts h a d b e e n a d mitt e d t o t h e  C hri sti e br e ast
c a n c er tri al, a n d of t h e f ort y  w o m e n o n t h e tri al f or  m or e t h a n t e n  w e e ks, all h a d
s h o w n  m e as ur a bl e a n d  m ar k e d t u m o ur r e gr essi o n.  T h e cli ni ci a ns c arr yi n g o ut t h e
tri al r e p ort e d h o w i m pr ess e d t h e y  w er e  wit h t h e l o w i n ci d e n c e a n d tri vi al n at ur e of
a n y si d e- eff e cts, es p e ci all y c o m p ar e d  wit h ot h er a g e nts,  w hi c h  w er e oft e n eit h er
t o xi c, or – i n t h e c as e of br e ast c a n c er – t e n d e d t o h a v e  m as c uli nisi n g eff e cts, a n d i n
s o m e i nst a n c es  w er e s o i nt ol er a bl e t h at p ati e nts h a d b e e n  wit h dr a w n fr o m
tr e at m e nt.2 4
2 1 Q uir k e, “ T a m o xif e n fr o m F ail e d  C o ntr a c e pti v e Pill. ”
2 2 Ri c h ar ds o n, “ T h e  Hist or y of  N ol v a d e x, ” A Z, P H 2 7 0 3 9  B.
2 3 I bi d.
2 4 N or et hi st er o n e  w as a dr u g  wit h s u c h a n dr o g e ni c eff e cts.
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I n r et ur n, t h e tri als pr o vi d e d cli ni c al  m at eri al f or l a b or at or y st u di es of t a m o xif e n.
B y t h e n, t h e o estr o g e n r e c e pt or h a d b e e n is ol at e d a n d i d e ntifi e d b y J a c k  G ors ki i n
t h e  U S, i n  w h at h as b e e n d es cri b e d as t h e “ first  m ol e c ul a r c h ar a ct eris ati o n of a
st er oi d h or m o n e r e c e pt or. ” 2 5 C o ns e q u e ntl y,  W al p ol e a n d his t e a m  w er e a bl e t o
d e vis e a r e c e pt or pr ot ei n- bi n di n g ass a y  m et h o d,  w hi c h s h o w e d t a m o xif e n t o b e a
c o m p etiti v e i n hi bit o r of o estr o g e n i n c ert ai n s p e ci es a n d or g a ns. 2 6 T h es e r es ults s u g-
g est e d t h at, li k e ot h e r a nti- o estr o g e n s, t a m o xif e n h a d a ki n d of a g o nist/ a nt a g o nist
p h ar m a c ol o gi c al a cti o n  wit h  w hi c h I CI r es e ar c h ers h a d b e c o m e f a mili ar i n t h eir
w or k o n t h e b et a- bl o c k e rs. 2 7 It h el p e d t o c ast f urt h e r li g ht o n t h e p h ysi ol o gi c al pr o-
c ess es at a  m ol e c ul ar l e v el, a n d  m a d e t a m o xif e n a p arti c ul arl y us ef ul r es e ar c h t o ol
f or i n v esti g ati o ns of h or m o n e- d e p e n d e nt t u m o urs.2 8
Gi v e n c o nfi d e n c e b y t h e cli ni c al a n d l a b or at or y st u di es c arri e d o ut s o f ar,  W al-
p ol e ’s t e a m b e g a n pl a n ni n g tri als i n c o ntr a c e pti o n, a n d t h e  N ol v a d e x  D e v el o p m e nt
Pr o gr a m m e  w as dr a w n u p.  T hi s  w as a n i m p ort a nt st e p pi n g-st o n e i n t h e dr u g ’s tr a ns-
f or m ati o n fr o m q u asi- or p h a n t o bl o c k b u st er dr u g, y et o wi n g t o u n c ert ai nti es i n t h e
dr u g ’s p ot e nti al  m ar k et, it  w as n e arl y st o p p e d.
T h e  N ol v a d e x  D e v el o p m e nt Pr o gr a m m e ( 1 9 7 1)
T h e “ D e v el o p m e nt Pr o g r a m m e ” w as a n or g a nis ati o n al i n n o v ati o n  w hi c h st a n d ar d-
is e d a n d c o difi e d t h e  R & D pr o c ess at I CI. I CI’s first  D e v el o p m e nt Pr o g r a m m e h a d
b e e n cr e at e d i n 1 9 6 4 f or t h e b et a- bl o c k er pr o pr a n ol ol. 2 9 T h e  N ol v a d e x  D e v el o p-
m e nt Pr o gr a m m e f oll o w e d s e v e n y e ars l at er, d es cri bi n g t h e  w or k d o n e u p t o J u n e
1 9 7 1, ass essi n g t h e dr u g ’s p ot e nti al  m ar k et, a n d  m a ki n g pl a ns f or f ut ur e  w or k.
T hr e e i m p ort a nt c o nsi d er ati o n s  w er e t a k e n i nt o a c c o u nt. First a n d f or e m ost  w er e
t a m o xif e n’s p ossi bl e cli ni c al us es, b as e d o n t h e r es ults of tri als r e c ei v e d t o d at e, i n-
cl u di n g t h e tr e at m e nt of o estr o g e n- d e p e n d e nt  m a m m ar y c ar ci n o m a. S e c o n d, t h e
dr u g ’s p ositi o n i n  N ort h  A m eri c a  w as u n d er q u esti o n, f oll o wi n g  A y erst ’s r ej e cti o n
of I CI ’s off er of t a m o xif e n f or t h e  A m eri c a n  m ar k et, a n d t h e F o o d a n d  D r u g  A d mi n-
istr ati o n ( F D A)’s li k el y n e g ati v e attit u d e t o w ar d s its us e i n br e ast c a n c er. 3 0 T hir d, t h e
c o m m er ci al sit u ati o n i n di c at e d t h at a n u m b er of tr e at m e nts of h or m o n e- d e p e n d e nt
br e ast c a n c ers  w er e alr e a d y i n e xist e n c e, e a c h of  w hi c h c o m m a n d e d al m ost e q u al
2 5 “ I n  M e m ori a m: J a c k  G ors ki ( 1 9 3 1– 2 0 0 6), ” E n d o cri n e  R e vi e ws 2 7, n o. 7 ( 1  D e c e m b er 2 0 0 6): 7 0 7 – 8.
2 6 W al p ol e et al.,  A Z  C P R 1 0 1/ 1 7 B  E n d o cri n ol o g y a n d F ertilit y ( 2 5 J u n e 1 9 7 0).
2 7 V.  Q uir k e, “ P utti n g  T h e or y i nt o Pr a cti c e: J a m e s  Bl a c k,  R e c e pt or  T h e or y, a n d t h e  D e v el o p m e nt of t h e  B et a- bl o c k ers at
I CI,” M e di c al  Hist o r y 5 0 ( 2 0 0 6): 6 9 – 9 2.  T a m o xif e n is n o w cl ass e d as a S el e cti v e  Estr o g e n  R e c e pt or  M o d ul at or
( S E R M) aft er t h e  A m eri c a n s p elli n g f or o estr o g e n,  m e a ni n g t h at it a cti v at es o estr o g e n r e c e pt ors i n s o m e tiss u es,
w hil e bl o c ki n g t h e m i n ot h ers.
2 8 V.  C. J or d a n,  M.  M.  C olli ns,  L.  R o ws b y, a n d  G. Pr e st wi c h, “ A  M o n o h y dr o x yl at e d  M et a b olit e of  T a m o xif e n  wit h
P ot e nt  A nti o estr o g e ni c  A cti vit y, ” T h e J o ur n al of  E n d o cri n ol o g y 7 5 ( 1 9 7 2): 2 8 9 – 9 8.
2 9 V.  Q uir k e, “ T h ali d o mi d e,  Dr u g S af et y  R e g ul ati o n a n d t h e  Britis h P h ar m a c e uti c al I n d ustr y:  T h e  C as e of I m p eri al
C h e mi c al I n d ustri es, ” i n M a ki n g  Dr u gs:  W a y s of  R e g ul ati n g b et w e e n F a ct o r y,  Offi c e,  C o ns ulti n g  R o o m a n d
C o urt , e d. J.- P.  G a u dilli èr e a n d  V.  H e ss ( B asi n gst o k e: P al gr a v e  M a c mill a n, 2 0 1 2), 1 5 1– 8 0.
3 0 T his n e g ati v e attit u d e  m a y h a v e b e e n d u e t o a 1 9 7 1 r e p o rt  w hi c h s u g g est e d t h at t h er e  w as a li n k b et w e e n  D E S a n d a
r ar e f or m of v a gi n al c a n c er, a n d  w as pr o m ptl y f oll o w e d b y a n F D A b ull eti n  w ar ni n g a g ai n st t h e us e of  D E S. F o o d
a n d  Dr u g  A d mi nistr ati o n, “ C ert ai n  Estr o g e ns f or  Or al or P ar e nt er al  Us e.  Dr u gs f or  H u m a n  Us e;  Dr u g  Effi c a c y St u d y
I m pl e m e nt ati o n,” F e d er al  R e gi st er 3 6, n o. 2 1 7 ( 1 9 7 1): 2 1 5 3 7 – 3 8.
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s h ar es of t h e  m ar k et.  N e v ert h el ess, t a m o xif e n h a d t w o a d v a nt a g es i n r el ati o n t o
br e ast c a n c er, o n  w hi c h its  m ar k et p ositi o n  w o ul d ulti m at el y d e p e n d: its u ni q u e
m o d e of a cti o n i n b ei n g a n o estr o g e n- a nt a g o nist  wit h o ut a n dr o g e ni c pr o p erti es;
a n d v er y l o w i n ci d e n c e of si d e eff e cts c o m p ar e d  wit h ot h er tr e at m e nts.
As  w ell as f urt h er tri als i n a n o v ul at or y i nf ertilit y (i n  A b er d e e n,  O xf o r d,  L o n d o n,
a n d  D u bli n), a n d i n br e ast c a n c er ( M a n c h est er,  Gl as g o w, a n d  L o n d o n), t h e  N ol v a-
d e x  D e v el o p m e nt Pr o gr a m m e i n cl u d e d c o ntr a c e pti v e tri als t o b e c arri e d o ut i n
S w e d e n.  T h es e tri als l e d t o t h e fi n di n g t h at, c o ntr ar y t o  w h at  mi g ht b e e x p e ct e d
fr o m t h e l a b or at or y st u di es i n r ats, e v e n at l o w d os es, t a m o xif e n sti m ul at e d
r at h er t h a n s u p pr ess e d o v ul ati o n, a n d t h er ef or e  w o ul d n ot  w or k as a c o nt r a c e pti v e
pill i n  w o m e n!  T h e  m ar k et f or a f ertilit y dr u g  w as s m all, li k e t h e  m ar k et f or a n a nti-
c a n c er dr u g, p artl y d u e t o t h e p o or pr o g n osis ass o ci at e d  wit h t h e dis e as e.  D es pit e
gr o wi n g cli ni c al e vi d e n c e of t h e us ef ul n ess of t a m o xif e n i n br e ast c a n c er, t h e v er y
l o w s al es esti m at es pr o d u c e d b y t h e  M ar k eti n g  D e p art m e nt s u g g est e d t h at it  w as
n e v er g oi n g t o c o v er  R & D c osts a n d bri n g a n a p pr o pri at e r et ur n t o t h e c o m p a n y.
I CI’s  M ai n  B o ar d t h er ef or e  m a d e t h e d e cisi o n t o cl os e d o w n t h e Pr o gr a m m e, b ut t a-
m o xif e n ’s c h a m pi o n i nsi d e t h e c o m p a n y,  W al p ol e, t hr e at e n e d t o r esi g n.  As a r es ult
of t his a n n o u n c e m e nt, d es p o n d e n c y s pr e a d t hr o u g h t h e e ntir e r es e ar c h d e p art m e nt.
M or e o v er,  w h e n i nf or m e d of t h e c o m p a n y ’s d e cisi o n, o n e cli ni ci a n s ai d t h at, i n vi e w
of t h e e n c o ur a gi n g tri al r es ults, I CI c o ul d n ot m or all y wit h dr a w t h e dr u g. 3 1 B y t h e n,
t h e br e ast c a n c er tri als h a d l e d t o a n u m b er of p u bli c ati o ns,  w hi c h s p ar k e d  w orl d-
wi d e i nt er est i n t a m o xif e n.  U n d e r s u c h pr ess ur e, a n d i n or d er t o pr es er v e t h e g o o d
i m a g e of t h e c o m p a n y, I CI r e v ers e d its d e cisi o n,  W al p ol e r e m ai n e d, a n d t h e pr oj e ct
w as s a v e d.
I n F e br u ar y 1 9 7 3 I CI t h er ef or e a p pli e d f or a pr o d u ct li c e n c e,  w hi c h  w as gr a nt e d a
f e w  m o nt hs l at er, a n d i n  O ct o b er of t h at y e ar t a m o xif e n  w as l a u n c h e d i n t h e  U K f or
b ot h a n o v ul at or y i nf ertilit y a n d t h e p alli ati v e tr e at m e nt of br e ast c a n c er.  Alt h o u g h
t h er e c o nti n u e d t o b e cr oss o v ers b et w e e n t h e t w o pr oj e cts, t h e r est of t his p a p er  will
f o c us o n br e a st c a n c er, a n d J or d a n’s r ol e i n r el ati o n t o it. It  will s h o w h o w t a m o xif e n
w as tr a nsf or m e d fr o m a r es e ar c h o bj e ct a n d p alli ati v e t h er a p y f or a d v a n c e d br e ast
c a n c er, i nt o a di a g n osti c a n d pr e di cti v e t o ol, a n a dj u v a nt c h e m o- e n d o cri n e tr e at-
m e nt first i n p ost- m e n o p a us al, t h e n als o i n pr e- m e n o p a us al  w o m e n  wit h e arl y
br e ast c a n c er, a n d e v e nt u all y i nt o t h e first c h e m o pr e v e nt ati v e f or c a n c er.
Cr ai g J or d a n, I CI a n d t a m o xif e n: fr o m p alli ati v e c ar e t o a dj u v a nt
t h er a p y ( 1 9 7 2– 1 9 7 5)
I CI’s t a m o xif e n pr oj e ct i ns pir e d t h e t o pi c of J or d a n ’s P h D, f u n d e d b y a  M R C s c h ol-
ars hi p a n d e ntitl e d “ A St u d y of t h e  O estr o g e ni c a n d  A nti o estr o g e ni c  A cti viti es of
S o m e S u bstit ut e d  Tri p h e n yl et h yl e n es a n d  Tri p h e n yl et h a n es. ” W al p ol e e x a mi n e d
3 1 Ri c h ar ds o n, “ T h e  Hist or y of  N ol v a d e x, ” A Z, P H 2 7 0 3 9  B; s e e als o  V.  C. J or d a n, “ T a m o xif e n:  A  m ost  M nli k el y Pi-
o n e eri n g  M e di ci n e, ” N at ur e  R e vi e ws  Dr u g  Dis c o v er y 2 ( 2 0 0 3): 2 0 5 – 1 3.
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his t h esis i n 1 9 7 2, d es pit e t h e  U ni v ersit y ’s dis a p pr o v al of a s ci e ntist fr o m i n d ustr y
e x a mi ni n g a u ni v e rsit y d o ct or at e, a n d J or d a n  w as a w ar d e d his P h D i n P h ar m a c ol-
o g y i n 1 9 7 3.  T h a n ks t o  B arr ett, n o w at  L e e ds  U ni v ersit y, h e  w as i m m e di at el y off er e d
a l e ct ur es hi p i n P h ar m a c ol o g y.  H o w e v er, at t h e ti m e, y o u n g  Britis h s ci e ntists  w er e
oft e n e n c o ur a g e d t o tr a v el t o  A m eri c a t o c o m pl et e f ell o ws hi ps b ef or e r es u mi n g
t h eir a c a d e mi c p osts b a c k i n t h e  U K (r ef err e d t o as “ B T A ” – b e e n t o  A m eri c a). 3 2
O n J or d a n ’s b e h alf,  W al p ol e t h er ef or e p h o n e d his f or m er c oll e a g u e  H ar p er, n o w
at t h e  W or c est er F o u n d ati o n f or  E x p eri m e nt al  Bi ol o g y ( M ass a c h us etts), b est
k n o w n f or t h e d e v el o p m e nt of t h e c o m bi n e d or al c o ntr a c e pti v e pill, a n d as a
r es ult J or d a n t o o k a l e a v e of a bs e n c e a n d s et off f or t h e  U S, r et ur ni n g t o t h e  U K
i n 1 9 7 4.
It  w as at t h e F o u n d ati o n t h at his f or m al r el ati o ns hi p  wit h I CI b e g a n – t o b e  m or e
pr e cis e its n e wl y a c q uir e d s u bsi di ar y St u art P h ar m a c e uti c als,  w h er e h e  w as i ntr o-
d u c e d b y  W al p ol e t o  L ois  Tr e n c h. J or d a n d es cri b e d h er as “ a  w o m a n  wit h a
M ast er ’s d e gr e e l o o ki n g aft er t h e l os er dr u g ( all of I CI  m e di ci n es i n cli ni c al st u di es
h a d  m al e p h ysi ci a ns d oi n g t h e r e al w or k … ).” 3 3 L u c kil y, s h e a gr e e d t o f u n d his r e-
s e ar c h.  T h us J or d a n b e c a m e I CI ’s “ First  T a m o xif e n  C o ns ult a nt, ” wit h t h e r ol e of d e-
v el o pi n g l a b or at or y st u di es “ t o g ui d e h o w b est t o us e t a m o xif e n i n cli ni c al tri als”
a n d of t al ki n g t o cli ni c al tri al gr o u ps i n t h e  U S, s u c h as t h e  E ast er n  C o o p er ati v e  O n-
c ol o g y  Gr o u p ( E C O G). 3 4 W hil e at t h e F o u n d ati o n, J or d a n a c q uir e d k n o wl e d g e a n d
t e c h ni q u es t h at  w o ul d pr o v e  m ost us ef ul b ot h t o hi m, a n d t o I CI: h e n ot o nl y st u di e d
wit h  El w o o d J e ns e n, t h e “ f at h er of t h e fi el d of h or m o n e a cti o n,” 3 5 b ut als o  wit h
W.  L.  M c G uir e,  w h o d e v el o p e d a  m et h o d f or pr e di cti n g r es p o ns es t o h or m o n e
t h er a p y usi n g t a m o xif e n.3 6
J or d a n  w o ul d c o nti n u e t o r e c ei v e gr a nts fr o m I CI ( a n d t h e n  Astr a Z e n e c a, f or m e d b y
t h e  m er g er of I CI’s s p u n- off p h ar m a c e uti c al di visi o n,  Z e n e c a, a n d t h e S w e dis h dr u g
c o m p a n y  Astr a) t hr o u g h his v ari o us a p p oi nt m e nts, first at  L e e ds u ni v ersit y ( 1 9 7 4 –
1 9 7 9), t h e n at t h e u ni v ersit y of  Wis c o nsi n ( 1 9 8 0 – 1 9 9 5) – w h er e  Astr a Z e n e c a pr o vi d e d
$ 1 0 0, 0 0 0 fr o m  Al d erl e y P ar k t o st art u p his l a b or at or y – a n d fi n all y at  N ort h w est er n
U ni v ersit y  M e di c al S c h o ol,  C hi c a g o, Illi n ois ( 1 9 9 3 – 2 0 0 4).  T his arr a n g e m e nt l ast e d
u ntil 2 0 0 2,  w h e n h e  w as n o mi n at e d f or a n  O B E b y  Dr  B arr y F urr, t h e n  C hi ef S ci e ntist
at  Astr a Z e n e c a, f or “ S er vi c es t o I nt er n ati o n al  Br e ast  C a n c er  R es e ar c h. ” H e  w as
a w ar d e d his  O B E s o o n aft er w ar ds.  At t his p oi nt h e b e g a n  w or ki n g  wit h  Eli  Lill y o n
S E R Ms, a p at h  w hi c h I CI c h os e n ot t o f oll o w, pr ef erri n g t o f o c us o n ar o m at as e i n hi b-
it ors i nst e a d, a n d his ass o ci ati o n  wit h t h e c o m p a n y c e as e d.3 7
3 2 J or d a n, “ I nt er a cti o n of  V  Cr ai g J or d a n  wit h st aff of I CI P h ar m a c e uti c als,  Z e n e c a a n d  Astr a Z e n e c a, 1 9 6 7 – 2 0 0 2 ” ( 0 2/
1 0/ 1 8).
3 3 I d e m, p ers. c o m m. ( 2 2/ 0 9/ 1 7).
3 4 I d e m, “ I nt er a cti o n.”
3 5 D.  M o or e, “ A  C o n v e rs ati o n  wit h  El w o o d J e ns e n, ” A n n u al  R e vi e w of  P h ysi ol o g y 7 4 ( 2 0 1 2): 1 – 1 1; “ I n  M e m ori a m –
Willi a m  L.  M c G uir e, ” Br e ast  C a n c er  R es a n d  Tr e at m e nt 2 3 ( 1 9 9 2): 7 – 1 5.
3 6 J or d a n ’s  C V  m e nti o ns t h at h e st u di e d t e c h ni q u es  wit h b ot h  m e n,  w h os e  w or k  w a s cit e d i n I CI r e p orts. J or d a n,
“ U p d at e d  E xt er n al  C. V. ” ( 2 8/ 0 3/ 1 8).
3 7 Q uir k e i nt er vi e w  wit h J or d a n ( 1 9/ 0 6/ 1 8).
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I n a p ers o n al c o m m u ni c ati o n, J or d a n  wr ot e:
D uri n g all of t h es e cl os e i nt er a cti o ns I  w as n e v er p ai d s al ar y or a n y r e m u n er ati o n fr o m
I CI. It  w as a p ur e a c a d e mi c i n v est m e nt b y I CI i n  m y st aff ( of  m y c h o osi n g)  w h o r e c ei v e d
s c h ol ars hi ps fr o m  m e i n I CI ’s n a m e t o g et t h eir P h D et c.  At  L e e ds  m y  w h ol e gr o u p  m et
e v er y 6  m o nt hs f or 4 y e ars  wit h  W al p ol e a n d St aff at  Al d erl e y P ar k.  T h eir i n v est m e nt i n
m y y o u n g t al e nt e d p e o pl e, cr e at e d a s o u n d st art t o t h eir s u c c essf ul f ut ur e c ar e ers. 3 8
B y str essi n g t h at h e h a d r e c ei v e d n o p ers o n al r e m u n er ati o n fr o m I CI, J or d a n hi g h-
li g ht e d his a n d his gr o u p’s i n d e p e n d e n c e fr o m a n y e xt er n al i nfl u e n c e, i n a  w a y t h at
pr es er v e d his i n cr e asi n gl y p u bli c r e p ut ati o n, a c hi e v e d at first o n a tr a ns atl a nti c, a n d
t h e n o n a gl o b al st a g e.
M e a n w hil e, I CI ’s t a m o xif e n pr oj e ct c o nti n u e d t o pr o gr ess i n  Brit ai n a n d  E ur o p e.
T h e gr o wi n g n u m b er of cli ni c al tri als s u g g est e d t o  W al p ol e t h at t a m o xif e n c o ul d b e
gi v e n t o pr e- m e n o p a us al  w o m e n  wit h br e ast c a n c er t o pr e di ct  w h et h er it  w o ul d b e
us ef ul t o s u bj e ct t h e m t o  m or e dr asti c tr e at m e nts, s u c h as r e m o v al of t h e o v ari es.  At
t h e s a m e ti m e, h e  m a d e pl a ns  wit h  Dr J e a n- Cl a u d e  H e us o n f or a tri al r u n b y t h e  E u-
r o p e a n  Or g a ni z ati o n f or  R es e ar c h a n d  Tr e at m e nt of  C a n c er ( E O R T C,  w hi c h h a d
b e e n cr e at e d i n 1 9 6 2).  T his i n cl u d e d o estr o g e n r e c e pt or d et er mi n ati o ns o n bi o psi es
t a k e n fr o m e a c h p ati e nt t o d et er mi n e  w h et h er t h er e  w as a c orr el ati o n b et w e e n cli n-
i c al r es p o ns e t o t h e c o m p o u n d a n d t h e pr es e n c e of o estr o g e n r e c e pt ors i n t h e t u m o ur
tiss u e.3 9 T a k e n t o g et h er, t h es e o bs e r v ati o ns l e d t o t h e h o p e t h at it  w o ul d b e p ossi bl e
t o pr e di ct t h e t y p e of p ati e nt li k el y t o r es p o n d t o tr e at m e nt  wit h t a m o xif e n, a n d
d e v el o p  w h at b e c a m e k n o w n as “ p ers o n ali z e d  m e di ci n e. ”
H o w e v er f or t his t o h a p p e n, a b ett er l a b or at or y  m o d el f or t u m o ur i n hi biti o n h a d
t o b e f o u n d.  T h e first st e p  w as t o d esi g n a si m pl er  m et h o d of r e c e pt or a n al ysis,
w hi c h c o ul d b e a p pli e d r o uti n el y o n a l ar g e s c al e i n t his  m o d el, b ef o r e b ei n g
a p pli e d i n h u m a ns.  W al p ol e ’s t e a m d e v el o p e d s u c h a  m et h o d i n c oll a b or ati o n
wit h J or d a n. 4 0 If it pr o v e d eff e cti v e, i. e. if it d e m o nstr at e d t h at t a m o xif e n c o ul d
bi n d t o t h e o estr o g e n r e c e pt or i n h u m a n br e ast t u m o urs, t h e t e a m h o p e d t h at t his
m et h o d  w o ul d  m a k e it p ossi bl e t o s cr e e n p ati e nts f or t h e pr es e n c e of s p e cifi c o estr o-
g e n r e c e pt ors i n bi o p s y s p e ci m e ns of t h eir t u m o urs a n d t o pr e-s el e ct f or tr e at m e nt
wit h t a m o xif e n t h os e i n  w h o m s u c h r e c e pt ors h a d b e e n f o u n d.
J or d a n’s p u bli c ati o n o n t h e s u bj e ct a p p e ar e d i n 1 9 7 4: 4 1 “ T his  w as t h e first r e p ort
t h at t a m o xif e n  w o ul d pr e v e nt r at  m a m m ar y c ar ci n o g e n esis a n d bl o c k e d estr a di ol
bi n di n g t o t h e h u m a n estr o g e n r e c e pt or fr o m br e ast t u m o urs.  T h e r e p ort is t h e
first t h at st art e d a s yst e m ati c e v al u ati o n of t h e dr u g as a br e ast c a n c er t h er a p y i n
A m eri c a [ si c].” 4 2 T h e c o nt e xt  w as ri p e f or t his t y p e of  w or k, a n d – j ust li k e
3 8 J or d a n, p ers. c o m m. ( 1 6/ 0 9/ 1 8).
3 9 W al p ol e et al., ( A Z  C P R 1 0 1/ 2 6 B F ertilit y, 2 2 J u n e 1 9 7 3).
4 0 W al p ol e et al., ( A Z  C P R 1 0 1/ 2 7 B F ertilit y 2 4  O ct. 1 9 7 3). S e e als o  M a xi m o v, T a m o xif e n , 4 0– 1.
4 1 V.  C. J or d a n, “ A ntit u m o ur  A cti vit y of t h e  A nti o estr o g e n I CI 4 6, 4 7 4 ( T a m o xif e n) i n t h e  Di m et h yl  B e n z a nt hr a c e n e
( D M B A)-i n d u c e d  R at  M a m m ar y  C ar ci n o m a  M o d el,” J. St er oi d  Bi o c h e m 5 ( 1 9 7 4): 3 5 4.
4 2 J or d a n, “ U p d at e d  E xt er n al  C. V. ”
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J or d a n – t a m o xif e n “ w as i n t h e ri g ht pl a c e at t h e ri g ht ti m e. ” 4 3 N ot o nl y h a d Pr es-
i d e nt  Ni x o n si g n e d i n 1 9 7 1 t h e  U S  N ati o n al  C a n c er  A ct,  w hi c h e n a bl e d  m e di ci n e s t o
m o v e r a pi dl y fr o m t h e l a b or at or y i nt o p ati e nt c ar e, b ut i n  W al p ol e ’s  w or ds, “ B y
g o o d f ort u n e,  N ol v a d e x  w as l a u n c h e d at a ti m e of i n cr e as e d i nt er est i n t h e ass ess-
m e nt of t h e e n d o cri n e st at us i n br e ast c a n c er. ” 4 4 T a m o xif e n  w as s h o w n t o b e
hi g hl y eff e cti v e i n bi n di n g t o t h e o estr o g e n r e c e pt or a n d, b ef o r e l o n g, r es e ar c h ers
i n  E ur o p e as  w ell as i n t h e  U S  w er e usi n g t h e dr u g as a t o ol t o “ pr e di ct t h e r es p o ns e
of br e ast t u m o urs t o h or m o n e t h er a p y. ” 4 5
N ol v a d e x  w as als o l a u n c h e d at a ti m e  w h e n t h e v al u e of c h e m ot h e r a p y i n c a n c er
w as b ei n g est a blis h e d  wit h n o v el dr u g s t est e d first al o n e, t h e n c o m bi n e d, i n c oll a b o-
r ati v e  m ulti- c e ntr e tri als.  Wit h dr u g r esist a n c e b e c o mi n g a gr o wi n g c o n c er n, n ot o nl y
i n b a ct eri a, b ut al s o i n c a n c er c ells, c o m bi n ati o n t h er a p y  w as b ei n g d e v el o p e d a n d its
m o d aliti es r efi n e d.  H e n c e, i n J u n e 1 9 7 4,  W al p ol e b e g a n pl a n ni n g a tri al  wit h t w o dif-
f er e nt tr e at m e nt  m o d aliti es, s u p p os e dl y d e v oi d of cr oss-r e sist a n c e, a n d h e pr o p os e d
t o alt er n at e t h eir a d mi nistr ati o n o n a f o ur- w e e k b asis.4 6 T his a p p r o a c h  w as
a d o pt e d b y  H e us o n at  E O R T C, al o n g si d e a n ot h er tri al i n pr e- m e n o p a us al  w o m e n. 4 7
S u c h pl a ns a n d dis c ussi o ns,  w hi c h  w er e b as e d o n a gr o wi n g n u m b er of p u bli c ati o ns
a n d s y m p osi a pr es e nti n g e vi d e n c e n ot o nl y of s y m pt o m r eli ef, b ut als o of r e missi o ns
a n d s ur vi v al fr o m br e ast c a n c er, 4 8 i n di c at e t h at, b ot h as a r es e ar c h t o ol a n d a t h er a-
p e uti c a g e nt, t a m o xif e n  w as s hifti n g fr o m p alli ati v e c ar e i nt o t h e r e al m of t h er a p y.
W h at f oll o ws  will c o n c e ntr at e o n t h e y e ars 1 9 7 5 – 1 9 8 0, aft er  w hi c h I CI ’s r es e ar c h
r e p orts o n t a m o xif e n a n d r el at e d t o pi cs e n d e d.  D uri n g t h at p eri o d  W al p ol e  w as
m ai nl y i n v ol v e d i n t h e  N ol v a d e x  D e v el o p m e nt Pr o gr a m m e, as a c o ns ult a nt hi ms elf
o n c e h e h a d r etir e d, u ntil his s u d d e n d e at h i n 1 9 7 7.  Alt h o u g h his i n v ol v e m e nt
e ns ur e d c o nti n uit y b et w e e n t h e r es e ar c h a n d d e v el o p m e nt p h as es,  W al p ol e ’s
gr a d u al dis e n g a g e m e nt fr o m t h e r es e ar c h,  w hi c h c a n b e d et e ct e d i n t h e r e p orts,
m e a nt t h at t h e pr oj e ct l a c k e d cl e ar p ur p os e a n d dir e cti o n.  M o nt hs  w er e l ost t o pr es-
s ur es of c o m p eti n g  w or k i nsi d e t h e c o m p a n y, a n d as p e cts of t h e r es e ar c h  w er e o ut-
s o ur c e d t o e xt er n al l a b or at ori es, t h e  m ost i m p ort a nt of  w hi c h  w as J or d a n ’s.
N e v ert h el ess, i n t h at ti m e, t h e f o u n d ati o ns  w er e l ai d f or t h e n e xt p h as e i n t a m o xif e n ’s
tr aj e ct or y, fr o m a dj u v a nt t h er a p y t o t h e first c h e m o pr e v e nt ati v e r e m e d y f or c a n c er.
1 9 7 5 – 1 9 8 0: t h e fi n al y e ar s of I CI ’s t a m o xif e n pr oj e ct
T h e p eri o d 1 9 7 5 – 1 9 8 0  w as t h er ef or e a fr uitf ul ti m e f or b ot h J or d a n a n d t a m o xif e n.
B y t h e n J or d a n h a d r es u m e d his l e ct ur es hi p at  L e e ds,  w h er e h e est a blis h e d a
4 3 P att ers o n, p ers. c o m m. ( 2 0/ 0 4/ 0 9).
4 4 E.  V. J e n s e n et al., “ Estr o g e n  R e c e pt ors a n d  Br e a st  C a n c er  R es p o ns e i n  C a n c er  T h er a p y, ” i n Pr e di cti o n of  R es p o ns e
i n  C a n c er  T h er a p y, e d.  T.  C.  H all ( W as hi n gt o n,  D C:  U S  G o vt Pri nti n g  Offi c e, 1 9 7 1), 5 5– 7 0.
4 5 W al p ol e et al., ( A Z  C P R 1 0 1/ 3 2 B F ertilit y 2 7 J u n e 1 9 7 5).  O n e of t h es e r es e ar c h ers  w as  W.  L.  M c G uir e.
4 6 W al p ol e ( A Z  C P R 1 0 1/ 2 8 B F ertilit y 1 4 J u n e 1 9 7 4).
4 7 W al p ol e ( A Z  C P R 1 0 1/ 3 2 B F ertilit y 2 7 J u n e 1 9 7 5).
4 8 B o n a d o n n a et al., “ C yt ot o xi c  C h e m ot h er a p y f or  M a m m ar y  C a n c e r, ” S y m p osi u m , P a d o v a, 8  A pr. 1 9 7 4, cit e d i n
W al p ol e ( A Z  C P R 1 0 1/ 2 8 B F ertilit y 1 6 J u n e 1 9 7 4).
3 0 0 VI VI A N E  Q UI R K E
“ T a m o xif e n  Te a m, ” w hi c h  w as f u n d e d b y a n e q ui p m e nt gr a nt fr o m t h e  Y or ks hir e
C a n c er  R es e ar c h  C a m p ai g n, as  w ell as a J oi nt  R es e ar c h S c h e m e b et w e e n  L e e ds
a n d I CI P h ar m a c e uti c als  wit h J or d a n a n d  W al p ol e as Pri n ci p al I n v esti g at ors. 4 9
T h e l att er pr o vi d e d  m o n e y i n t h e f or m of I CI S c h ol ars hi ps f or l a b  m e m b ers a n d
r ats f or t h e e x p eri m e nts.  T h e p art pl a y e d b y  Dr.  R o y  C ott o n, t h e cli ni c al r es e ar c h er
r es p o nsi bl e f or c o or di n ati n g t h e t a m o xif e n st u di es at I CI,  w as es p e ci all y i m p ort a nt,
as h e arr a n g e d all t h e i nt er a cti o n b et w e e n J or d a n ’s gr o u p a n d I CI. J or d a n d es cri b e d
it t h us:
Dr  R o y  C ott o n [ … ]  w as t ol d n ot t o s p e n d t o o  m u c h ti m e o n t h e dr u g as it  w as  N O T
e x p e ct e d t o s u c c e e d.  H e  w as t h e i n n o v at or  w h o s e nt h u n dr e ds of r ats e a c h  w e e k f or
m y r es e ar c h at  L e e ds b y I CI c h a uff e ur e d c ars.  Wit h o ut t h at I c o ul d n ot c o m e o ut  wit h
t h e str at e g y of  L o n g  Ter m a dj u v a nt t a m o xif e n t h er a p y a n d  C h e m o pr e v e nti o n, b ot h
F D A a p pr o v e d a n d us e d  w orl d wi d e. 5 0
T wi c e a y e ar, J or d a n ’s t e a m  w e nt o v er t o  Al d erl e y P ar k t o pr es e nt t h eir fi n di n gs.
T h e y r e p ort e d t h at: t a m o xif e n c o ul d pr e v e nt r at  m a m m ar y c ar ci n o m a; l o n g er a dj u-
v a nt t a m o xif e n t h er a p y  w as b ett er t h a n s h ort er ( 1 – 2 y e ars) a dj u v a nt t a m o xif e n
t h er a p y; a n d o nl y p ati e nts  wit h o estr o g e n-r e c e pt or p ositi v e t u m o urs  w o ul d
b e n efit fr o m t a m o xif e n t h er a p y. J or d a n a gr e e d t o d ef er p u bli c ati o n o n o n e of
t h eir k e y fi n di n g s, t h e  m et a b oli c a cti v ati o n of t a m o xif e n t o 4- h y dr o x yt a m o xif e n
( w hi c h is 1 0 0 ti m es  m or e eff e cti v e t h a n t a m o xif e n at bl o c ki n g t h e o estr o g e n r e c e p-
t or)  w hil e t h e c o m p a n y s et o ut t o p at e nt all of t a m o xif e n’s  m et a b olit e s. J or d a n  w as
n ot i n vit e d t o b e a c o- p at e nt h ol d er.  H e l at er r efl e ct e d: “ I  w as n ot i nt er est e d i n a n y-
t hi n g b ut  m e di c al pr o gr ess. F or  m e g etti n g t a m o xif e n o n t h e  m ar k et i n  A m eri c a  w as
d e ar t o  m y h e art.  T h at ’s  w h at I  w as d oi n g – cr e ati n g a pl a n t o s a v e  w o m e n ’s li v e s.” 5 1
N e v ert h el ess, t h os e y e ars l ai d t h e f o u n d ati o ns f or J or d a n ’s f ut ur e  w or k o n
S E R Ms.  D uri n g t h at ti m e, J or d a n  wr ot e a b o ut t hirt y s ci e ntifi c p a p ers.  His first
p a p er est a blis hi n g t h e n e w str at e g y of l o n g t er m a dj u v a nt t a m o xif e n tr e at m e nt
w as p u blis h e d i n c o nf er e n c e pr o c e e di n gs f oll o wi n g a S y m p osi u m at  Ki n g ’s
C oll e g e,  C a m bri d g e 2 8 – 2 9 S e pt e m b er 1 9 7 7. 5 2 A m o n g t h e p arti ci p a nts  w er e:
Cr ai g J or d a n;  Mi c h a el  B a u m, l at er t o l e a d t h e  N ol v a d e x  A dj u v a nt  Tri al  Or g a ni z a-
ti o n ( N A T O), t h e first tri al t o s h o w a s ur vi v al a d v a nt a g e f or p ati e nts t a ki n g t a m o x-
if e n; a n d  H el e n St e w art,  w h o l e d t h e S c ottis h  Tri al of fi v e y e ars of a dj u v a nt
t a m o xif e n vs n o tr e at m e nt,  wit h t a m o xif e n tr e at m e nt u p o n first r el a ps e.
Alt h o u g h n eit h er t h e S c ottis h  Tri al n or t h e  N A T O p u bli c ati o ns  m e nti o n e d t h e l a b-
or at or y st u di es fr o m J or d a n ’s l a b or at or y,  w hi c h  m a y h a v e l e d t o a n u n d er-
esti m ati o n of his c o ntri b uti o n t o t his p h as e i n t h e hist or y of t a m o xif e n, J or d a n ’s
r ol e  w as b e gi n ni n g t o b e r e c o g nis e d i n ot h e r  w a ys, i n cl u di n g b y t h e c o m p a n y
its elf. I n 1 9 7 8, o n t h e o c c asi o n c el e br ati n g t h e  Q u e e n’s  A w ar d f or  Te c h n ol o gi c al
4 9 M a xi m o v et al., T a m o xif e n ,  C h. 3; J or d a n, “ I nt er a cti o n.”
5 0 J or d a n, p ers. c o m m. ( 1 6/ 0 9/ 1 8).
5 1 J or d a n, p ers. c o m m. ( 2 2/ 0 9/ 1 7).
5 2 V.  C. J or d a n, “ Us e of t h e  D M B A-i n d u c e d  R at  M a m m ar y  C ar ci n o m a S yst e m f or t h e  E v al u ati o n of  T a m o xif e n as a
P ot e nti al  A dj u v a nt  T h er a p y, ” R e vi e ws o n  E n d o cri n e- r el at e d  C a n c e r ( 1 9 7 8,  O ct. S u p pl.): 4 9– 5 5.
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A c hi e v e m e nt f or  T a m o xif e n, h e  w as t h e o nl y i n vit e e n ot t o b e a n e m pl o y e e of I CI.
T his  w as t h e first i n a l o n g list of h o n o urs a n d a w ar ds J or d a n  w o ul d r e c ei v e f or
his  w or k,  w hi c h b e c a m e cr u ci al t o t h e s ur vi v al of t a m o xif e n aft er 1 9 8 0,  w h e n
St e p h e n  C a rt er l eft t h e c o m p a n y, h a vi n g t a k e n e arl y r etir e m e nt, a n d t h e pr oj e ct
o n c ell gr o wt h  w as t er mi n at e d.  T h us  w h e n t a m o xif e n  w as bri n gi n g i n si z e a bl e
pr ofits f or t h e c o m p a n y a n d  Z ol a d e x (f or pr ost at e c a n c er)  w as i n t h e pi p eli n e, I CI
h a d n o l o n g er a c a n c er r es e ar c h pr o g r a m m e, a sit u ati o n t h at l ast e d u ntil 2 0 0 6,
w h e n  Al d erl e y P ar k b e c a m e t h e  Gl o b al  L e a d  C e ntr e f or  Astr a Z e n e c a ’s c a n c er
r es e ar c h.
J or d a n, t a m o xif e n, a n d b e y o n d – 1 9 8 0 – 2 0 0 0
T h a n ks t o t a m o xif e n, I CI  w er e a bl e t o t a p i nt o a gl o b al c a n c er r es e ar c h n et w or k
c o n n e ct e d i n  E ur o p e t hr o u g h t h e  E O R T C, a n d i n t h e  U S t hr o u g h t h e  N ati o n al
C a n c er I nstit ut e ( N CI).  B y t h e n, t h e c o m p a n y h a d alr e a d y s u b mitt e d a n I n v esti g a-
ti o n al  N e w  Dr u g (I N D) a p pli c ati o n t o t h e F D A. It  w as f oll o w e d i n 1 9 7 6 b y a
N e w  Dr u g  A p pli c ati o n ( N D A) t o t h e F D A ’s  O n c ol o gi c al  D r u gs  A d vis or y  C o m mit-
t e e, i n  w hi c h J o h n P att ers o n, a  m e m b er of I CI’s  Cli ni c al  R e s e ar c h  D e p art m e nt (f or-
m erl y of t h e  M e di c al  D e p art m e nt),  m a d e a d et ail e d a n d c o n vi n ci n g c as e f or t h e us e
of t a m o xif e n i n br e ast c a n c er, b as e d i n p art o n t h e b asi c r es e ar c h c arri e d o ut b y
J or d a n ’s l a b. 5 3 Alt h o u g h I CI ’s a p pli c ati o n f or a  U S p at e nt f or t a m o xif e n h a d ori gi-
n all y b e e n r ej e ct e d, t h a n ks t o t h e u nr el e nti n g eff orts of I CI p at e nt att or n e y P et er
Sl at c h er, 5 4 i n 1 9 8 5 t h e  A m eri c a n c o urt of a p p e als fi n all y gr a nt e d I CI t h e p at e nt
ri g hts f or t a m o xif e n i n t h e  U S A, t h er e b y st arti n g t h e s e v e nt e e n- y e ar p at e nt c o v e r
t h er e, p ar a d o xi c all y at a ti m e  w h e n p at e nt ri g hts  w er e c o mi n g t o a n e n d i n ot h er
c o u ntri es. 5 5
A n d t h er e  w as a n ot h er  w a y i n  w hi c h J or d a n,  w h o i n 1 9 8 0  m o v e d t o  Wis c o nsi n
w h er e h e b e c a m e  Assist a nt Pr of ess or of  H u m a n  O n c ol o g y a n d P h ar m a c ol o g y,
pl a y e d a n i m p ort a nt p art:
As I  w as c o nsi d er e d a n e x p ert a b o ut t h e ori gi ns o n t h e a ct u al str at e gi c d e cisi o n t o
d e v el o p t a m o xif e n as a t ar g et e d t h er a p y t o tr e at a n d pr e v e nt br e ast c a n c er, I CI ’s l a w
fir m s o u g ht  m y s er vi c es t o ai d t h e m ( b y t h e n  Z e n e c a) d ef e n d t h eir p at e nts i n t h e  U S i n
t h e l at e 8 0s.  T his  w as a J u d g e d e cisi o n al o n e tri al f or t hr e e  w e e ks.  A Z  w o n a n d t h e
J u d g e r ul e d i n t h eir f a v o ur b as e d, as h e st at e d i n his  writt e n d e cisi o n, o n  m y e vi d e n c e
b y n a m e. I  w as p ai d f or  m y ti m e as a n e x p ert  wit n ess i n t h e S m al ki n c as e i n  B alti m or e.
I  w as a n a d vis or t o t h eir l a w fir m at a s u bs e q u e nt c as e i n  B ost o n.  A g ai n t his  w as  w o n.
O v er all t his s a v e d t h e  A Z  m ulti billi o n  m ar k et i n t h e  U S,  w hi c h  w as b ei n g r ei n v est e d t o
d e v el o p  C as o d e x, F asl o d e x,  Z ol a d e x a n d  Ari mi d e x.  T his o n e dr u g t a m o xif e n cr e at e d t h e
f u n ds a n d f ut ur e of  A Z as t h e  C a n c er  C o m p a n y it is t o d a y [… ]  T a m o xif e n h as a f ull
p at e nt lif e i n t h e r est of t h e  w orl d b ut n o n e i n t h e  U S u ntil 1 9 8 5  w h e n t h e y o bt ai n e d
5 3 Ri c h ar ds o n, “ T h e  Hist or y of  N ol v a d e x, ” A Z, P H 2 7 0 3 9  B.
5 4 Hill, Al d erl e y  P ar k, 1 9 7.
5 5 M a xi m o v et al., T a m o xif e n , 4 0.
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a f ull p at e nt lif e i n t h e c o u ntr y  w h o e m br a c e d t a m o xif e n b ut t h er e dr u g  w as n ot p at e nt e d
u ntil t h e n – n o ot h er c o m p a ni es c ar e d as c h e m ot h er a p y [ usi n g c yt ot o xi c dr u gs]  w as ki n g
a n d  w o ul d c ur e  A L L c a n c ers. 5 6
T a m o xif e n ’s e ntr y i nt o t h e  A m eri c a n  m ar k et c o ntri b ut e d t o risi n g  w orl d wi d e s al es: al-
t h o u g h I CI’s  M ar k eti n g  D e p art m e nt h a d o nl y e x p e ct e d it t o  m a k e £ 1 0 0, 0 0 0 p. a. i n
1 9 7 0, b y 1 9 7 4 fi g ur es o n t h e h o m e  m ar k et al o n e a m o u nt e d t o £ 1 4 0, 0 0 0, o v ert a ki n g
o n e of I CI ’s  w ell est a blis h e d dr u gs  M ys oli n e (f or e pil e ps y).  B y 1 9 7 6, s al es fi g ur es
w er e e q ui v al e nt t o t h os e f or t h e a n a est h eti c Fl u ot h a n e, t h e first dr u g t o p ut I CI ’s P h ar-
m a c e uti c al  Di visi o n “ i n t h e bl a c k,” a n d f or o v er-t h e- c o u nt er dr u gs s u c h as t h e a ntis e p-
ti c S a vl o n.  As t h e e x pir y d at e f or t h eir t a m o xif e n p at e nts  w as dr a wi n g n e ar, i n 1 9 7 9 I CI
o bt ai n e d a f o ur- y e ar e xt e nsi o n f or t h eir  U K p at e nt, o n t h e b asis of “ t h e n at ur e a n d
m erits of t h e i n v e nti o n i n r el ati o n t o t h e p u bli c, ” as  w ell as “ t h e pr ofits  m a d e b y t h e p at-
e nt e e. ” 5 7 B y 1 9 8 0, it  w as  m a ki n g £ 3 0  milli o n f or t h e fir m. 5 8 N e v ert h el ess, e v e n as l at e
as S e pt e m b er 1 9 8 2, at t h e a n n u al p ortf oli o r e vi e w att e n d e d b y t h e  m a n a g ers of t h e
Bi ol o g y  D e p art m e nt ( Dr. J.  D. Fit z g er al d) a n d  C h e mistr y ( Dr.  R.  Cl ar c ks o n), t h e
m a n a g er of t h e  M ar k eti n g  D e p art m e nt,  w h o als o att e n d e d t h e  m e eti n g, c o m m e nt e d
t h at “ t h er e  w as n o  m ar k et f or c a n c er.” 5 9 I CI’s  M ar k eti n g  D e p art m e nt  w er e n ot
al o n e i n u n d er- esti m ati n g t h e  m ar k et f or a nti- c a n c er dr u gs: if t a m o xif e n h a d n ot
b e e n “ st ol e n” b y  A m eri c a n c o m p a ni es  w hil e it r e m ai n e d u n pr ot e ct e d b y p at e nts, it
w as p artl y b e c a us e t h e y di d n ot b eli e v e i n its us ef ul n ess eit h er. 6 0 T h e f at e of t a m o xif e n
t h er ef or e r est e d o n t h e q u aliti es of t h e dr u g its elf, a n d t h e i nt er est it g e n er at e d n ot o nl y
a m o n g r es e ar c h ers b ot h i nsi d e a n d o utsi d e t h e c o m p a n y, b ut als o – as I h a v e ar g u e d els e-
w h er e – a m o n g p ati e nts a n d t h e  wi d er p u bli c. 6 1
A s eri es of tri als t hr o u g h o ut t h e 1 9 9 0s a n d 2 0 0 0s h el p e d t o est a blis h its r e p ut ati o n
f urt h er, d es pit e t h e n e wl y dis c o v er e d li n k b et w e e n t a m o xif e n a n d e n d o m etri al
c a n c er. 6 2 T h e tri als i n cl u d e d t h e  Br e ast  C a n c er Pr e v e nti o n  Tri al  N S A B P- P 1
( B C P T),  wit h t h e ai m of est a blis hi n g  w h et h er fi v e y e ars of t a m o xif e n  w o ul d
r e d u c e t h e i n ci d e n c e of i n v asi v e br e ast c a n c er i n  w o m e n i d e ntifi e d as b ei n g at
hi g h ris k of t h e dis e as e. It st art e d i n 1 9 9 3 a n d l ast e d fi v e y e ars,  wit h J or d a n as
m e m b er of t h e  R e cr uit m e nt, Pr o m oti o n a n d  C o m pli a n c e  C o m mitt e e f or t h e d ur a-
ti o n of t h e tri al.  T his  w as f oll o w e d b y a n ot h er tri al, c o m p ari n g t a m o xif e n  wit h a
s e c o n d g e n e r ati o n S E R M, r al o xif e n e, c o d e- n a m e d S T A R, of  w hi c h h e  w as S ci e ntifi c
C h air m a n b et w e e n 2 0 0 1 a n d 2 0 0 8. 6 3
5 6 J or d a n, p ers. c o m m. ( 1 6/ 0 9/ 1 8).  U nf ort u n at el y, b e c a us e t h e i nf or m ati o n  w as c o m m er ci all y s e nsiti v e a n d I CI  w o n t h e
c as es, a c c ess t o t h e d o c u m e nts pr o d u c e d i n c o urt is n ot p ossi bl e.
5 7 U K 1 9 4 9 P at e nts  A ct, S e cti o n 2 3. htt p:// w w w.l e gisl ati o n. g o v. u k/ u k p g a/ 1 9 4 9/ 8 7/ p dfs/ u k p g a _ 1 9 4 9 0 0 8 7 _ e n. p df ( a c-
c ess e d 1 5 J u n e 2 0 1 7). I t h a n k  Dr.  Mi c h a el J e w e ss f or p oi nti n g o ut t his s e cti o n t o  m e.
5 8 Ri c h ar ds o n, “ T h e  Hist or y of  N ol v a d e x, ” A Z, P H 2 7 0 3 9  B.
5 9 Dr J. D. Fit z g er al d, p ers. c o m m. ( 0 1/ 1 1/ 1 3).
6 0 M a xi m o v et al., T a m o xif e n , 4 0.
6 1 Q uir k e, “ T a m o xif e n fr o m F ail e d  C o ntr a c e pti v e Pill. ”
6 2 V. J.  Assi kis a n d  V.  C. J or d a n, “ A  R e alisti c  Ass ess m e nt of t h e  Ass o ci ati o n b et w e e n  T a m o xif e n a n d  E n d o m etri al
C a n c e r, ” E n d o cri n e- R el at e d  C a n c er 2 ( 1 9 9 5): 2 3 5 – 4 1.
6 3 D.  L.  Wi c k er h a m, “ T a m o xif e n  Vers us  R al o xif e n e i n t h e Pr e v e nti o n of  Br e ast  C a n c er, ” E ur o p e a n J o ur n al of  C a n c er
3 8, S u p pl 6 ( 2 0 0 2): S 2 0 – 1.
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J or d a n s u m m aris e d his c o ntri b uti o n t h us:
I  w as i nstr u m e nt al i n t h e dis c o v er y pr o c ess f or r al o xif e n e a n d p u blis h e d t h e str at e g y f or
S E R Ms first. 6 4 Eli  Lill y  E V E N T U A L L Y  m o v e d o n t h at i d e a a n d c o nfir m e d  m y e arl y
r es ults.  T h e y e m br a c e d  m e as t h e c h air of a c o m mitt e e t o e v al u at e br e ast c a n c er i n ci-
d e n c e i n t h eir ost e o p or osis tri al  wit h r al o xif e n e. I c o ul d c h o os e  m y o w n c o m mitt e e
w hi c h I di d.  All gr e at s u c c ess  wit h a g ai n a bl o c k b ust er dr u g (i e a billi o n $ i n s al es a n-
n u all y, li k e t a m o xif e n i n t h e  U S aft er its p at e nt  w as a w ar d e d i n 1 9 8 5).  D eli g ht e d t h e y
f oll o w e d  m y l e a d a n d e m br a c e d S E R Ms. I g ot el e ct e d t o t h e  N ati o n al  A c a d e m y of S ci-
e n c es ( 2 0 0 9) a n d  M e di ci n e ( 2 0 1 7) [ … ]  w as el e ct e d o n t h e first r o u n d t o t h e F ell o ws hi p of
t h e  A c a d e m y of  M e di c al S ci e n c es ( 2 0 0 9).6 5
B y t h e n, i n p art as a r es ult of t h e a w ar ds a n d r e c o g niti o n h e r e c ei v e d, J or d a n h a d
als o b e c o m e a k e y s o ur c e of i nf or m ati o n o n a n d  m aj or c o ntri b ut or t o t h e hist or y
of t a m o xif e n: h e h as b e e n t h e s u bj e ct of a n d/ or pr o d u c e d at l e ast 1 5 bi o gr a p hi c al
a c c o u nts, i n cl u di n g a tri b ut e t o  Art h ur  W al p ol e, 6 6 a n d is t h e a ut h or of n u m er o us
r e vi e w a n d r etr os p e cti v e c h a pt ers a n d arti cl es o n t a m o xif e n a n d S E R Ms  m or e
g e n er all y.
J or d a n’s c o ntri b uti o n  w as a c k n o wl e d g e d b y  Astr a Z e n e c a, i n a Pr o gr a m of  Hist or-
i c al  Mil est o n es  C el e br ati n g its 2 5 y e ars as a “ c a n c er ” c o m p a n y, at S a n  A nt o ni o,
Te x as, i n 2 0 0 3:
T w o cli ni c al  A w ar ds a n d t w o c h e mist  A w ar ds  w er e pr es e nt e d [ … ]  W a k eli n g a n d J or d a n
r e c ei v e d t h e c h e mist pri z e.  W a k eli n g, a n  Astr a Z e n e c a e m pl o y e e, is cr e dit e d  wit h t h e dis-
c o v er y a n d d e v el o p m e nt of F asl o d e x as t h e first p ur e a nti estr o g e n f or t h e tr e at m e nt of
br e ast c a n c er. J or d a n pr o vi d e d t h e tr a nsl ati o n al r es e ar c h t o j ustif y t h e us e of t a m o xif e n
as a l o n g t er m a dj u v a nt t h er a p y a n d as t h e first c h e m o pr e v e nt ati v e a g e nt t o r e d u c e t h e
ris k of br e ast c a n c er i n hi g h ris k  w o m e n. 6 7
His cit ati o n  w as as “ i nt er n ati o n all y r e c o g ni z e d f or his r es e ar c h t h at h as r es ult e d i n
gr o u n d- br e a ki n g tr e at m e nt of br e ast c a n c er. ” 6 8
C o n cl u si o n
J or d a n h as r e c ei v e d  wi d e r e c o g niti o n as “ t h e f at h e r of t a m o xif e n.” 6 9 H o w e v er, his
r ol e as “ t h e First  T a m o xif e n  C o ns ult a nt” h as l ar g el y r e m ai n e d i n visi bl e, as h as t h e
f a ct t h at t a m o xif e n als o h a d a “ m ot h er. ” D or a  Ri c h ar ds o n c arri e d o ut t h e s y nt h esis
of t a m o xif e n, a n d of s e v er al of its  m et a b olit e s, t h us h el pi n g t o p a v e t h e  w a y f or
6 4 V.  C. J or d a n,  E. P h el ps, a n d J. U.  Li n d gr e n, “ Eff e cts of  A nti estr o g e ns o n  B o n e i n  C astr at e d a n d I nt a ct F e m al e  R ats, ”
Br e ast  C a n c er  R es e ar c h a n d  Tr e at m e nt 1 0 ( 1 9 8 7): 3 1 – 5.  T his p u bli c ati o n,  w hi c h d es cri b e d t h e – p ar a d o xi c al – pr o-
t e cti v e eff e ct of t a m o xif e n o n b o n e, h as b e e n a c k n o wl e d g e d b y ot h er s as h a vi n g “ r e v ol uti o ni z e d t h e  w a y  w e h a v e
c o m e t o t hi n k of n u cl e ar r e c e pt or f u n cti o ni n g. ” C. P.  Mill er, “ S E R M s:  E v ol uti o n ar y  C h e mistr y,  R e v ol uti o n ar y
Bi ol o g y, ” C urr e nt  P h ar m a c e uti c al  D esi g n 8, n o. 2 3 ( 2 0 0 2): 2 0 8 9 – 1 1 1
6 5 J or d a n, p ers. c o m m. ( 1 7/ 0 9/ 1 8).
6 6 V.  C. J or d a n, “ T h e  D e v el o p m e nt of  T a m o xif e n f or  Br e ast  C a n c er  T h er a p y:  A  Tri b ut e t o t h e  L at e  Art h ur  L.  W al p ol e, ”
Br e ast  C a n c er  R es.  Tr e at. 1 1, n o. 3 ( 1 9 8 8): 1 9 7 – 2 0 9.
6 7 J or d a n, “ D o c u m e nt a r y e vi d e n c e ” ( 0 4/ 0 5/ 1 9).
6 8 I bi d.
6 9 Br y a n, “ Q & A. ”
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s u bs e q u e nt S E R Ms.  Alt h o u g h s h e h as n u m er o us s ci e ntifi c p a p ers a n d at l e ast a
c o u pl e of p at e nts t o h er n a m e, f ar l ess is k n o w n a b o ut h er t h a n J or d a n, 7 0 i n p art
b e c a us e s h e  w as n ot a n a c a d e mi c a n d n e v er l eft t h e c o m p a n y, b ut als o p er h a ps
b e c a us e s h e  w as a  w o m a n i n t h e v er y  m al e- d o mi n at e d  w orl d of i n d ustri al c h e mis-
tr y.7 1 H er hist or y of t a m o xif e n  w as  m ai nl y f or i nt er n al c o ns u m pti o n, dr a wi n g
u p o n h er e x p eri e n c e as p arti ci p a nt i n a f ort y- y e ar pr o g r a m m e of i n d ustri al r es e ar c h
i n v ol vi n g a  m ultit u d e of e xt er n al c oll a b or at or s, a n d i n 1 9 8 0,  w h e n s h e  wr ot e h er
a c c o u nt, J or d a n  w as o n e a m o n gst  m a n y.  Alt h o u g h b y t h e n t a m o xif e n  w as alr e a d y
s h o wi n g s u c c ess as br e ast c a n c er a dj u v a nt t h er a p y, s h e di d n ot h a v e t h e s a m e hi n d-
si g ht as J or d a n,  w h os e hist ori c al c o ntri b uti o n s tr a ci n g t a m o xif e n ’s j o ur n e y t o bl o c k-
b ust er dr u g a n d t h e v er y first c h e m o pr e v e nt ati v e  m e di ci n e f or c a n c er  w o ul d c o m e
t hirt y y e ars l at er.
T his ti m e-l a g  m a y e x pl ai n s o m e of t h e g a ps or dis cr e p a n ci es b et w e e n t h e t w o a c-
c o u nts,  w hi c h o nl y h a d p arti al k n o wl e d g e of t h e ot h er si d e ’s i nfl u e n c e a n d c o ntri b u-
ti o n, a n d  w hi c h t his p a p er h as att e m pt e d t o c o m bi n e a n d r e c o n cil e. It als o  m a y h a v e
l e d t o a diff er e nt u n d erst a n di n g a n d a p pr e ci ati o n of  w h at c o nstit ut es t h e i m p ort a nt
p h as es i n t h e i n n o v ati o n pr o c ess: o n t h e o n e h a n d, t o a n i n d u stri al c h e mist, t h e l o n g
a n d p ai nst a ki n g i n v est m e nt i n s ci e ntifi c a n d t e c h ni c al, as  w ell as t h e or g a nis ati o n al
eff ort, t h at u n d er pi ns t h e dis c o v er y of a n e w dr u g; o n t h e ot h er, t o a n a c a d e mi c p h ar-
m a c ol o gist, t h e str at e gi c t hi n ki n g a n d pl a n ni n g, as  w ell as t h e d o g g e d d et er mi n ati o n,
r e q uir e d f or it t o s u c c e e d i n t h e  m e di c al  m ar k et pl a c e.
W h e n I i nt er vi e w e d J or d a n i n J u n e 2 0 1 8, I as k e d hi m  w h y h e t h o u g ht littl e
m e nti o n  w as  m a d e of his n a m e i n  Ri c h ar ds o n ’s a c c o u nt as  w ell as i n I CI ’s i nt er n al
r e p orts.  H e r e pli e d t h at c o m p a ni es ar e hi g hl y i nt er n al or g a nis ati o ns. 7 2 C o nsi d e ri n g
t h e l o n g hist or y of I CI  w or ki n g cl os el y  wit h e xt er n al c oll a b or at ors,  w h et h er u ni v er-
sit y a c a d e mi cs or h os pit al cli ni ci a ns, i n c or p or ati n g t h eir k n o wl e d g e a n d k n o w- h o w
i nt o i nt er n al r es e ar c h pr o g r a m m es, a n d oft e n citi n g t h e r el e v a nt lit er at ur e, I a m n ot
c o n vi n c e d t his is e ntir el y tr u e. 7 3 N e v ert h el ess, t h er e s e e m e d t o b e a n u n d er esti m ati o n
of e a c h ot h e r ’s r ol es, i n p art d u e t o t h e v eil of s e cr e c y t h at is pr es e nt at t h e b o u n d ar y
b et w e e n t h e t w o s p h er es,  w hi c h h as t h e eff e ct of  m ai nt ai ni n g r at h er t h a n diss ol vi n g
t h at b o u n d ar y, a n d t o t h eir diff er e nt p ers p e cti v es – wit h o n e si d e  m or e i nt er est e d i n
a c a d e mi c r e p ut ati o n, a n d p er h a ps l ess i n fi n a n ci al r e w ar d t h a n t h e ot h er.
7 0 D or a  N elli e  Ri c h ar ds o n  w as b or n i n  Wi m bl e d o n i n 1 9 1 9.  A p p ar e ntl y s h e “ h a d d e ci d e d o n h er lif e ’s  w or k  w h e n
s e ei n g p e o pl e  w or ki n g i n h os pit al l a b or at ori es,  w hil e visiti n g h er d yi n g gr a n d m ot h er i n  L o n d o n ’s  C a n c er  H os pit al. ”
Hill, Al d erl e y  P ar k, 1 9 0. S h e o bt ai n e d a  B S c i n c h e mistr y fr o m  U ni v ersit y  C oll e g e,  L o n d o n i n 1 9 4 1, st art e d  w or k at
I CI i n 1 9 4 3 o n s y nt h eti c a nti- m al ari als, a n d o bt ai n e d h er P h D ( pr es u m a bl y als o fr o m  U C L) o n a r el at e d t o pi c i n
1 9 5 3. S h e  w or k e d at I CI u ntil s h e r etir e d, a n d di e d i n St o c k p ort,  C h es., i n 1 9 9 8. I t h a n k  G err yl y n n  R o b erts a n d
G e off a n d  M ar el e n e  R a y n er- C a n h a m f or  m a ki n g s o m e of t h es e d et ails a v ail a bl e t o  m e. F or  m or e o n  w o m e n c h e mists
s e e  R a y n er- C a n h a m, C h e mistr y  w as t h eir  Lif e:  Pi o n e er  Britis h  W o m e n  C h e mists, 1 8 8 0 – 1 9 4 9 ( L o n d o n: I m p eri al
C oll e g e Pr ess, 2 0 0 8).
7 1 W h e n s h e s y nt h e si z e d t a m o xif e n, i n 1 9 6 2, s h e  w as p ai d 8 0 % of t h e s al ar y of h er  m al e c oll e a g u e s.  Hill, Al d erl e y  P ar k,
1 9 5.
7 2 Q uir k e i nt er vi e w  wit h J or d a n.
7 3 S e e f or i nst a n c e  G.  K.  R o b erts, “ D e ali n g  wit h Iss u es at t h e  A c a d e mi c-I n d ustri al I nt erf a c e i n I nt er- W ar  Brit ai n:  U ni-
v ersit y  C oll e g e  L o n d o n a n d I m p eri al  C h e mi c al I n d ustri es, ” S ci e n c e a n d  P u bli c  P oli c y 2 4, n o. 1 ( 1 9 9 7): 2 9 – 3 5.
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W h e n I i nf or m e d J or d a n t h at I i nt e n d e d t o us e his i nt er vi e w f or a p a p er o n his c o n-
tri b uti o n t o t h e t a m o xif e n st or y,  m or e s p e cifi c all y his r ol e as c o ns ult a nt t o I CI, h e
str ess e d: “ I r e c ei v e d u nr estri ct e d gr a nts fr o m I CI i n  A m eri c a a n d  L e e ds. I us e d t his t o
f u n d t h e s al ari es ( Te c h ni ci a ns, s c h ol ars hi ps a n d P h D s al ari es) f or  m y gr o u p. I h a d n o
fi n a n ci al c o nt a ct, a n d a ut o n o m y t o d o as I  w a nt e d i n r es e ar c h.” 7 4 Yet h e r ef err e d t o
hi ms elf as “ t h e First  T a m o xif e n  C o ns ult a nt.” 7 5 T his s h o ws t h e fl e xi bilit y of t h e t er m,
w hi c h is c o nti n g e nt o n ti m e a n d pl a c e, a n d,  m or e s p e cifi c all y p er h a ps, t h e i n d ustri al
s e ct or t o  w hi c h it is a p pli e d. I n t h e p h ar m a c e uti c al i n d ustr y, it h as oft e n l e d t o  m or al
dil e m m as a n d c o m pr o mis es, h ei g ht e n e d aft er t h e S e c o n d  W orl d  W ar  w h e n a dis c o urs e
of “ p ur e s ci e n c e ” d e v el o p e d a n d c o m m er ci al pr ofits fr o m r es e ar c h  w er e i n cr e asi n gl y
fr o w n e d u p o n.7 6 H e n c e str essi n g o n e ’s  m or al a n d fi n a n ci al i n d e p e n d e n c e fr o m dr u g
c o m p a ni es is n ot u n c o m m o n, a n d I h a v e e n c o u nt er e d it els e w h er e.
T h e q u esti o n r e m ai ns of h o w t y pi c al t h e r el ati o ns hi p b et w e e n I CI a n d J or d a n  w as.
Alt h o u g h it  w as n ot u n us u al f or fir ms t o e m pl o y c o ns ult a nts a n d o uts o ur c e t h eir r e-
s e ar c h t o e xt er n al b o di es b y t h e 1 9 7 0s – 1 9 8 0s, 7 7 t h e a c a d e mi c cr e d e nti als of I CI’s
st aff,  m a n y of  w h o m c o ul d  m o v e al m ost s e a ml essl y b et w e e n t h e r e al ms of i n d u str y
a n d a c a d e mi a, or  w o ul d r e c ei v e a c a d e mi c r e c o g niti o n s u c h as F ell o ws hi ps of t h e
R o y al S o ci et y,  w as q uit e e x c e pti o n al.  As t o J or d a n, h o w e x c e pti o n al h e  w as i n
t er ms of t h e e xt e nt t o  w hi c h t a m o xif e n’s s u c c e ss d e p e n d e d o n hi m  mi g ht b est b e a n-
s w er e d b y r efl e cti n g o n t h e s p e cifi c n at u r e of c a n c er r es e ar c h i n t h e p eri o d d uri n g
w hi c h h e c oll a b or at e d  wit h I CI. I n a fi el d at t h at ti m e d o mi n at e d b y c yt ot o xi c c h e-
m ot h er a p y, b ut als o  m arr e d  wit h u n c ert ai nt y, a n d d e p e n d e nt o n e xt er n al ( g o v er n-
m e nt al a n d c h arit a bl e) s o ur c es of f u n di n g, 7 8 fir ms  m a y h a v e f elt a n e v e n gr e at er
n e e d t o r el y o n c o ns ult a nts t o e n h a n c e t h eir i m a g e as r es e ar c h i nstit uti o ns, as  w ell
as t o pr o vi d e t h e m  wit h s ci e ntifi c k n o wl e d g e a n d t e c h ni c al e x p ertis e. J or d a n u n-
d o u bt e dl y br o u g ht I CI all of t h es e, a n d i n r et ur n b e n efit e d fr o m t h e pr o bl e ms a n d
pr o d u cts pr o vi d e d b y t h e c o m p a n y.  T a m o xif e n  w as a n o utst a n di n g pr o d u ct, t h e
first of its ki n d, a n d f u n cti o n e d b ot h as a r es e ar c h t o ol a n d a t h er a p y.  Li k e
J or d a n, it cir c ul at e d a cr oss t h e b o u n d ar y b et w e e n a c a d e mi a a n d i n d ustr y. S u c h
“ b o u n d ar y o bj e cts, ” a n d t h e fi el ds or s e ct ors a m o n g  w hi c h t h e y cir c ul at e, als o
n e e d t o b e t a k e n i nt o a c c o u nt i n hist ori es of c o ns ult a n c y.
A c k n o wl e d g e m e nt s
I a m gr at ef ul t o  Cr ai g J or d a n  w h o h as b e e n  m ost g e n e r o us  wit h his ti m e, as  w ell as
t h e  writt e n  m at eri als a n d or al r e c oll e cti o ns  w hi c h h e ki n dl y s h ar e d  wit h  m e. I a m
7 4 J or d a n, p ers. c o m m. ( 1 7/ 0 9/ 1 9).
7 5 J or d a n, “ I nt er a cti o n.”
7 6 Q uir k e, C oll a b or ati o n; s e e als o  R.  B u d ’s c o m m e nt pi e c e i n t his s p e ci al iss u e.
7 7 J.  M er c eli s,  G.  G al v e z- B e h ar, a n d  A.  G u a g ni ni, “ C o m m er ci ali zi n g S ci e n c e:  Ni n et e e nt h a n d  T w e nti et h- c e nt ur y  A c a-
d e mi c S ci e ntists as  C o ns ult a nts, P at e nt e es a n d  E ntr e pr e n e ur s, ” Hist or y a n d  T e c h n ol o g y 3 3, n o. 1 ( 2 0 1 7): 4 – 2 2 ( o n
6 – 7).
7 8 R.  B u d, “ Str at e g y i n  A m eri c a n  C a n c e r  R es e ar c h aft er  W orl d  W ar II:  A  C as e St u d y, ” S o ci al St u di es of S ci e n c e 8
( 1 9 7 8): 4 2 5– 5 9.
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als o i n d e bt e d t o t h e ot h er s ci e ntists a n d cli ni ci a ns  w h os e  m e m ori es h a v e h el p e d t o
i nf or m  m y u n d erst a n di n g of t h e hist or y of t a m o xif e n. I t h a n k  Astr a Z e n e c a f or
gr a nti n g  m e a c c ess t o t h eir u n p u blis h e d c o m p a n y r e p orts at v ari o u s ti m es
b et w e e n 2 0 0 3 a n d 2 0 0 9, a n d t h e  Well c o m e  Tr ust f or f u n di n g  m y r es e ar c h ( gr a nts
n u m b er: 0 9 5 6 8/ Z/ 1 1/ A, 0 8 6 8 4 3/ Z/ 0 8/ Z).
F u n di n g
T his  w or k  w as s u p p ort e d b y  Well c o m e  Tr ust: [ gr a nt n u m b er 0 9 5 6 8/ Z/ 1 1/ A,
0 8 6 8 4 3/ Z/ 0 8/ Z].
N ot e s o n c o ntri b ut or
Dr Vi vi a n e  Q uir k e is S e ni or  L e ct ur er i n  M o d er n  Hist or y a n d  Hist or y of  M e di ci n e at
O xf or d  Br o o k es  U ni v ersit y.  H er r es e ar c h ar e a is t h e hist or y of bi o m e di c al k n o wl-
e d g e a n d pr a cti c e, t h er a p e uti c i n n o v ati o n a n d t h e p h ar m a c e uti c al i n d u str y.
A d dr ess: S c h o ol of  Hist or y, P hil os o p h y a n d  C ult ur e,  O xf or d  Br o o k es  U ni v ersit y,
G y ps y  L a n e,  O xf o r d  O X 3 0 B P.  E m ail: v q uir k e @ br o o k e s. a c. u k.
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